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ABSTRACT 
Infectious swine diseases have the potential to decimate the health and productivity of 
swine farms. One of the most economically concerning diseases is caused by the Porcine 
Reproductive and Respiratory Syndrome (PRRS) virus. While swine producers can implement 
vaccines, medications, or antibiotics and antiviral drugs, many infectious pathogens such as the 
PRRS virus have shown these strategies to be ineffective. One complimentary strategy would be 
to select pigs for increased disease resistance or resilience, where disease resilience is defined as 
an animal’s ability to maintain performance when infected. However, the elite populations that 
are used for genetic improvement are typically kept in high health conditions, making it difficult 
and impractical for swine breeders to use phenotypic selection in an environment with exposure 
to disease to select for increased disease resilience. Previous research has shown that host 
response to PRRS virus infection has a sizable genetic component and revealed a Quantitative 
Trait Locus (QTL) for host response to PRRS virus infection on Sus Scrofa Chromosome (SSC) 
4. A putative causative mutation in the GBP5 gene was identified for this QTL. This mutation 
was determined to be in complete linkage disequilibrium with the single nucleotide 
polymorphism (SNP) WUR10000125 (WUR) that was included on commercial SNP panels. 
However, this was based on data from one genetic source.  
The overall objective of this thesis was to determine if the WUR SNP and phenotypes 
obtained from in-vitro mitogen stimulation assays (MSA) of peripheral blood mononuclear cells 
(PBMCs) from young healthy nursery pigs can be used as genetic indicators to select for disease 
resilience. The two requirements for a genetic indicator are that it must be heritable and have a 
sizeable genetic correlation with the trait of interest, in this case, disease resilience. Data from 
experimental PRRS virus infection trials from the PRRS Host Genetics Consortium (PHGC) and 
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a polymicrobial Natural Disease Challenge Model (NDCM) of grow-finish pigs were used to 
address these objectives.  
Data and SNP genotypes, including for the WUR SNP and the putative causative 
mutation in the GBP5 gene, were available on 1414 pigs from eight PHGC trials of ~200 
commercial crossbred nursery pigs per trial from six unrelated populations. Results showed that 
the WUR and GBP5 SNPs were not in complete linkage disequilibrium (r2 = 0.94). Discordant 
genotypes were determined to be the result of recombination, rather than genotyping errors. 
Although it was previously speculated that the GBP5 gene is a major gene responsible for host 
response to PRRS, there were small but non-significant differences between the effect of GBP5 
and WUR on PRRS viral load and weight gain post-infection. These results indicate that either 
GBP5 or the WUR SNP can be used for marker-assisted selection to increase resistance to 
PRRS.  
In the NDCM, data from 3139 crossbred nursery barrows that were genotyped using a 
650 K SNP Panel (Affymetrix) were used. The 650 K panel included the WUR SNP but not the 
GBP5 SNP. In the NDCM, pigs were entered through a batch system of 60 or 75 pigs per batch 
into a facility that was seeded with multiple infectious pathogens, including PRRS, to maximize 
the expression of disease resilience. Disease resilience traits, including growth, feed intake, and 
treatment and mortality rates were recorded. Based on these data, it was determined that the 
favorable G allele for the WUR SNP was significantly associated with greater average daily gain 
(p=0.02) and lower numbers of treatments in the challenge nursery (p=0.05) and across the 
challenge nursery and finisher (p=0.01), establishing the effect of the SSC4 QTL on resilience to 
a polymicrobial disease challenge.  
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For the MSAs, PBMCs were isolated from blood samples of 882 pigs from 19 batches of 
the NDCM, taken at 27 or 35 days of age and prior to their entry in the disease challenge. For the 
MSAs, PBMCs were stimulated with five unique mitogens: Concanavalin A (Con A), 
Phytohemagglutinin (PHA), Poke Weed Mitogen (PWM), Lipopolysaccharide (LPS), and 
Phorbol Myristate Acetate (PMA), and evaluated for counts of proliferated cells after 48, 72, and 
96 hours compared to unstimulated samples (restcount). Proliferated cell counts were adjusted 
for restcount in two ways: 1) by dividing the average cell count of the stimulated wells by the 
average cell count of the non-stimulated wells, to compute a Blastogenic Index Score (BIS), and 
2) by including the average cell count of the non-stimulated wells as a covariate in the model for 
analysis of the average cell count of the stimulated wells. Data on BIS and stimulated means at 
each time point were analyzed separately for each mitogen. For pigs that had data at all three 
time points for a mitogen, data across these time points were incorporated into a single 
phenotype called the Area Under the Curve (AUC). Differences between pairs of time points for 
a given mitogen (delta = 72 – 48 hrs, 96 – 72 hrs, and 96 - 48 hrs) were also analyzed as 
phenotypes. Genetic parameters (heritabilities and genetic correlations) were estimated for the 
MSA phenotypes. In general, MSA phenotypes based on BIS versus stimulated means adjusted 
for restcount had similar estimates of genetic parameters. Heritability estimates for the Con A, 
PHA, and PMA MSA phenotypes were moderate, ranging from 0.13 +0.09 to 0.37 +0.10 for Con 
A, from 0.10 +0.07 to 0.34 +0.09 for PHA, and from 0.05 +0.06 to 0.30 +0.10 for PMA. 
Heritability estimates for the PWM and LPS MSA phenotypes were low, ranging from 0.00 
+0.00 to 0.15 +0.09. Disease-related phenotypes collected on these same pigs in the NDCM were 
then used to estimate genetic correlations of the MSA phenotypes with disease resilience 
phenotypes. Phenotypic correlations between MSA and disease resilience phenotypes were low. 
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Phenotypes derived from the Con A, PHA, and PMA MSAs, however, had moderately high 
estimates of genetic correlations with several disease resilience traits, although none were 
significantly different from zero due to large standard errors. However, genetic correlation 
estimates were generally in the expected direction, with pigs with higher MSA response having 
better resilience at the genetic level. Overall, Con A presented itself as the most promising 
mitogen to use as a genetic indicator for disease resilience, although further studies are 
recommended to validate its potential and to determine the ideal time point or MSA phenotype to 
use. 
In conclusion, the use of a genetic indicator to indirectly select for increased disease 
resilience in swine is a viable approach. The two indicators investigated in this thesis, i.e. 
genotype at an SNP on chromosome 4 and results of an in vitro mitogen stimulation assay on 
immune cells derived from the blood of young healthy piglets, are suitable genetic indicators for 
disease resilience to a polymicrobial disease challenge.   
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CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
Genetic improvement of swine has resulted in large increases in several desired 
production traits in the US pork industry. The impact of infectious swine diseases, however, 
persists as an economic problem. One such pathogenic disease is Porcine Reproductive and 
Respiratory Syndrome (PRRS), caused by the PRRS virus, which increases reproductive failures 
in sows and mortality in younger pigs. One study estimated that the PRRS virus costs the US 
Pork industry 665 million dollars each year (Holtkamp et al., 2013). Due to the severity of this 
disease, the National Pork Board (NPB) funded the PRRS Host Genetics Consortium (PHGC) in 
2007, a community of PRRS researchers collaborating with industry to develop strategies to 
combat PRRS by increasing host response to PRRS virus infection (Lunney et al., 2011).  
While selection for production traits continues to increase revenue for producers, one 
reason why swine diseases linger as an economical problem in the pork industry may be due to 
the “Resource Allocation Theory” (Rauw, 2007). Based on this theory, animals that are selected 
for increased production efficiency have genetic pressure to allocate energy resources to those 
traits, leaving less energy to be allocated to other energy-demanding traits, for example, the 
immune response to a pathogenic threat. Therefore, as animals in the market are more and more 
selected for production efficiency, there is a dire need to also consider their ability to fend off 
disease. A parallel concept is the term “disease resilience” which describes the productiveness of 
an animal during the course of an infection (Albers et al., 1987; Doeschl-Wilson et al., 2012; 
Mulder and Rashidi, 2017). Fortunately, in principle, selection is not limited to just production 
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traits and can also include selection on disease resilience traits. However, several issues need to 
be overcome to improve disease resilience in commercial swine through genetic selection.  
To understand the challenges of selecting for disease-related traits in the swine industry, 
the foundations of the swine industry must first be discussed. There are large genetic and 
phenotypic differences between pigs from different lines and breeds. By crossing these parental 
lines, producers can take advantage of each breed’s specialties, as well as heterosis (Fragomeni 
et al., 2016). To exploit the economic benefits of heterosis, the structure of the pork industry in 
the United States has evolved from backyard pigs into what can be best described as a three-
tiered pyramid structure, as illustrated in Figure 1.1.  
 
Figure 1.1: Structure of the US Swine Industry. 
 
The very top tier consists of the nucleus populations, elite groups of pigs of the parental 
breeds or lines that are intensely and meticulously selected for specific production traits. These 
pigs tend to be from purebred breeds or lines. Some of the specific dam and sire lines utilized as 
nucleus populations are from the Landrace, Yorkshire, and Duroc breeds. The Landrace, 
Nucleus
Multiplier
Commercial
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Yorkshire, and Large White are considered “maternal breeds”, as their lines are recognized and 
selected for traits such as litter size and weaning weight (Bidanel et al., 1994). On the other hand, 
the Duroc and Hampshire are considered “paternal breeds”, as these breeds are recognized for 
traits such as meat color, carcass size, and other desirable meat quality traits (Nowachowicz et 
al., 2000). 
Nucleus herds are typically of limited size (500 to 2000 sows). For these herds to provide 
sufficient breeding animals to meet the needs of commercial pork production, one or more 
multiplier levels are included, in particular on the maternal side. The multipliers have a larger 
population size than the nucleus and exploit the advantages of crossing the purebred lines, in 
particular, to produce F1 females on the maternal side by crossing the Landrace and the 
Yorkshire breeds, to capitalize on maternal heterosis (Johnson et al., 1975). 
The pork that consumers purchase is not from either the nucleus or the multiplier pigs, 
but the commercial pigs. The base of the three-tiered pyramid is occupied by the commercial 
swine herd. These swine are the offspring of the multiplier pigs and have the largest population 
size among the three tiers. The pork that consumers purchase is from the commercial swine herd, 
leaving great reason for them to be concerned about the welfare and the health of commercial 
swine. 
Overall, the pyramid structure allows genetics from the nucleus herd to cascade into the 
commercial herd. Each tier consists of different sized populations, housing environments, 
management techniques, and risk of disease. In particular, because of their value, nucleus herds 
are kept under high biosecurity units to ensure the protection of these pigs from infectious 
pathogens that are commonly found in commercial barns. In addition, international or interstate 
4 
 
transport of swine germplasm can require a health certificate. Thus, when disease enters a 
nucleus herd, the possibility of germplasm being sold from this herd could be eliminated, a huge 
financial detriment for swine companies that commercialize high-quality boar sperm and 
animals. 
Due to the multi-tiered pyramid structure of the pork industry, to create genetic change in 
the commercial swine herd, genetic change must be implemented upstream in the nucleus tier. In 
principle, a disease challenge could be performed in the nucleus herd to observe and allocate the 
animals that should be used in selecting for higher disease-related traits. However, this is 
problematic for two main reasons. First, it is not cost-effective to put the nucleus herd through a 
disease challenge because all of them may die or permanently lose their production ability due to 
disease. Second, the presence of a disease in the nucleus would prevent germplasm to be 
marketed from this population. Instead, the nucleus herds must be kept as healthy and intact as 
possible to provide the desired genetics for the lower tiers in the pyramid. In order to 
circumnavigate these two problems, the use of genetic indicators for disease-related traits could 
be considered for selection in the nucleus.  
Genetic indicators are traits that can be used for selection to genetically improve a target 
trait, instead of selecting directly on the target trait (Oliver et al., 1958). Genetic indicator traits 
are used when the target trait is difficult to select for directly because the desired trait may not be 
observed, such as the maternal ability of male hogs, or if traits are measured too late, such as 
carcass traits. There are multiple requirements for a genetic indicator to be effective but, 
specifically, they must be (1) heritable and (2) the genetic indicator must be genetically 
correlated with the target trait. The underlying genetic mechanism that allows for the latter is 
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pleiotropy, in which a given gene influences two or more phenotypes (Paaby et al., 2013). 
Historically, farmers would use selective breeding (artificial selection) of animals, choosing 
animals based on observable phenotypes that indicated favorable traits (Wykes, 2004). More 
recently, the use of genetic markers has been implemented as a tool to be used in marker assisted 
selection. This strategy relies on genetic markers, which are genes or variations in DNA 
sequences that can be used to identify genetic characteristics of an organism that are associated 
with a phenotype. Commonly used genetic markers include restriction fragment length 
polymorphisms and single nucleotide polymorphisms (SNPs) (Collar et al., 2008).  
The first study in this thesis explored the effect of genotype at genetic marker 
WUR10000125 (WUR) on performance in a polymicrobial disease challenge to determine if 
genotype at the WUR marker could be a possible indicator for disease resilience. Previous 
studies have shown that pigs with the favorable genotype at this genetic marker had greater 
resistance and resilience to a PRRS disease challenge (Boddicker et al. 2012) and that this 
genetic marker was in complete linkage disequilibrium with the putative causative mutation for 
host resistance to PRRS in the nearby GBP5 gene (Koltes et al. 2015). Thus, the objectives of 
this study were to 1) investigate the relationship of genotype at the WUR SNP with genotype at 
the putative causative mutation in the GBP5 gene, 2) compare the association of the WUR versus 
the GBP5 SNP with host response to PRRS virus infection, and 3) determine whether the WUR 
SNP is also associated with resilience to a polymicrobial disease challenge.  
The second study in this thesis used mitogens as an immune cell stimulant in vitro to 
determine if the rate of peripheral blood mononuclear cell (PBMC) proliferation in stimulated 
blood from young healthy piglets can be used as a genetic indicator for disease resilience. As 
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mentioned earlier, genetic indicators must be heritable and genetically correlated to a target trait. 
Thus, the objectives of this study were to determine estimates of genetic parameters of these 
mitogen stimulation assays (MSAs), i.e. the heritability of PBMC proliferation rate following 
stimulation with various mitogens at different time points after stimulation, and the genetic 
correlations of these proliferation rates with disease resilience traits.  
Thesis Organization 
  The second chapter of this thesis is a review of the current literature related to genetic 
selection for disease resilience in growing pigs. Topics discussed include the mammalian 
immune response to pathogens, the impact of PRRS and other swine pathogens on disease 
resilience, measurement of disease resilience phenotypes using in vitro assays, and the genetics 
of disease and resilience. The third chapter reports on a study of the analysis of differences in 
disease resilience phenotypes based on genotype at the WUR marker, to determine if the WUR 
genotype can be used as a genetic indicator to resilience under a polymicrobial disease challenge. 
The fourth chapter describes results from mitogen stimulation assays (MSAs) in blood collected 
from innate naïve piglets, to determine whether they can be used as genetic indicators for disease 
resilience. Chapter 5 discusses the key results obtained from these two studies and how results 
can contribute to the improvement of disease resilience in commercial growing pigs. Chapter 3 is 
formatted for the journal Livestock Science and Chapter 4 is formatted for the Journal of Animal 
Science. All data were obtained from the PHGC and the NDCM, which was implemented at the 
Centre de développement du porc du Québec (CDPQ) in Quebec, Canada.  
For the studies described in Chapter 3, I (Ryan Jeon) conducted the statistical and 
bioinformatic analyses of the effect of the WUR genotype on disease resilience, while Dr. Qian. 
7 
 
Dong conducted the analyses of the PHGC data. Jian Mark Cheng and Dr. Austin Putz from 
Iowa State University created the dataset, consisting of all disease resilience phenotypes used for 
analysis and provided a polished genotype file that included the WUR marker. The disease 
resilience data were collected as part of a large-scale natural disease challenge study that was 
held in facilities at CDPQ. Interpretation of results from the PHGC trials was done by Qian Dong 
and me. The interpretation of results from CDPQ was done by me. The results in this chapter 
were written and prepared by me.  
For the studies described in Chapter 4, I conducted the statistical analyses on exploring 
the prospect of using results from MSAs as genetic indicators for disease resilience in growing 
pigs. The MSA assays were designed by Dr. Jenny Phipps from Metadis Inc. and were 
completed and compiled by Dr. Caroline Gilbert from the University of Laval and by Dr. John 
Harding from the University of Saskatchewan. The methods section regarding the mitogen 
stimulation assay protocol was written by Dr. Caroline Gilbert and Dr. John Harding. The 
remaining methods section was written by me. The rest of this chapter was written and prepared 
by me. Chapter 5 was prepared by me.  
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CHAPTER 2. LITERATURE REVIEW 
Quantitative Genetics 
The study of animal genetics was born from an intent for animal breeders to acquire a 
better understanding of the inheritance of economically desired traits in their flocks, herds, and 
litters. The value of an animal as a parent can be measured by the expression of an animal's 
genetics into phenotypes. These phenotypes can be visible or non-visible and can be categorized 
as either quantitative or qualitative phenotypes. Qualitative phenotypes are often visible traits 
that are measured subjectively and divided into categories. These traits are often controlled by 
one or a few genes. However, there are many polygenic qualitative genes, such as those affecting 
the health status of an animal (healthy or sick). On the other hand, quantitative traits show 
continuous expression and are numerically measured. These traits are controlled by many genes, 
causing complexity in determining the contribution of each gene on a given quantitative trait. 
Phenotype is not limited to just the genetics, however. The environment an animal is in will also 
influence the phenotype. An animal with superior genetics will not realize its full potential if the 
environment is not conducive to growth. For instance, an animal heavily selected for production 
traits may not reach an expected level of production, if the environment has high disease 
pressure.  
An animal's phenotype is determined by genetics and environment, however, only 
genetics is inherited. The definition of heritability from a statistical perspective is the proportion 
of observed variance for the trait that can be attributed to inherited genetic factors, rather than the 
environment (Wray and Visscher, 2008). In other words, it is the proportion of variation in a 
population of a given phenotype that is due to genetic variation. Heritability runs from a scale of 
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0 to 1, where high heritability is considered to be greater 0.4, while traits that are lowly heritable 
range from 0 to 0.2. The heritability of a trait is not concrete and can differ between species, 
lines, and given enough time, even within the same population.  
Heritability is fundamentally important to the accuracy and efficiency of selection 
because it can be used as a measure of how well the performance of a particular trait from the 
offspring will resemble the performance of its parents. Take for instance, the most rudimentary 
form of selection, phenotypic selection. In this method, animals are selected solely based on their 
own observable phenotype. One particular example would be to select parents based on their 
own resilience to disease. If the heritability of resilience to disease was high, then the parent’s 
performance would be a great indicator of the offspring’s performance. On the contrary, if 
heritability was low, then the offspring would be unlikely to resemble their parents for this trait. 
Modern selection these days utilizes more information than just the own observable phenotype, 
for instance phenotypes of relatives and, more recently, genotyping data. However, this example 
delineates the importance of heritability in selection.   
There are many methods to improve a population of animals (inbreeding, line-breeding, 
outcrossing), but there are two key components that are central to all of these. The first is 
selection, in which animal breeders must choose which animals become parents, as well as how 
long each animal will stay in the breeding program. The second is non-random mating, in which 
animal breeders must choose the male and female parents to mate to create offspring. Until the 
1970s, the selection of the animals was determined from an animal's observable phenotype. It 
was only until the arrival of genetic markers that the possibility for selection based on genotype, 
rather than observable phenotype was attained.  
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A Brief History of Genetic Markers 
Genetic variation describes differences in DNA sequences between individuals in a 
population (Barton and Keightley, 2002). These differences are due to polymorphisms, or 
changes in the DNA sequence that can create variation of a trait in a population. Each individual 
carries two copies of nucleotide sequence at each part of the genome (pairs of chromosomes), but 
not every nucleotide sequence will be identical. The simplest polymorphism involves variation at 
one base pair, for instance, a guanine substituted for a cytosine. These are called single 
nucleotide polymorphisms (SNP) and are the most common types of polymorphisms observed 
(Teama, 2018). 
DNA polymorphisms can be used as markers identify and locate quantitative trait loci 
(QTL). QTL are regions on the genome that are found to be statistically associated with the 
variation in phenotype between individuals at a quantitative trait, which can be used to find 
candidate genes responsible for trait variation. 
 Markers can be separated into two classes: biochemical and molecular. Biochemical 
markers represent variation at the protein level, e.g., differences in the form or function of 
proteins, while molecular markers represent variation at the DNA level, for instance, base pair 
changes or repeated sequences. The next sections will introduce some of the biochemical and 
molecular markers that were commonly used to find the underlying genetic basis of trait 
variation.  
 Alloenzymes: The first markers used were alloenzymes. Alloenzymes are biochemical 
markers and can be described as allelic variants of enzymes (Schlötterer, 2004). If an amino acid 
substitution in DNA causes changes to a protein, this can be measured by using native gel 
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electrophoresis. This allows visualization of polymorphisms through different colored bands that 
change based on the charge and size of the protein variant. Several studies have used 
alloenzymes to study genetic variation in a wide variety of animals, such as humans, Drosophila, 
and the wild boar. The Lang et al., (2000) found a potential genetic marker in the wild boar that 
was associated to resistance against swine fever by utilizing alloenzymes. They determined that 
by comparing enzyme polymorphisms before and after a devastating swine fever, the allele 
frequency at the phosphoglucomutase locus (PGM-2) changed substantially, indicating evidence 
that animals with a favorable allele at this locus may be more resistant to swine fever.  
Alloenzymes are still used today in populations with large sample sizes, as historically 
they were one of the most cost-efficient genetic markers. However, the biggest limitation with 
alloenzymes is that they have limited coverage because the number of informative loci is small. 
Another limitation is that alloenzymes measure the product of a polymorphism, not the DNA 
itself, meaning it is difficult to know the number and location of mutations that explain the 
polymorphism. Last, the procedure can be laborious and with the advent of DNA sequencing 
technology, the use of alloenzymes has dwindled (Schlötterer, 2004).   
 Restriction Fragment Length Polymorphisms (RFLPs): Restriction enzymes were the 
first molecular, or DNA level markers, to be used. The use of RFLP’s involve the use of a group 
of enzymes that search for a specific sequence of nucleotides, also known as restriction sites, and 
cleave fragments of DNA near these sites. This can be exploited to explore polymorphisms in 
DNA. If a nucleotide base pair has been switched to another, the restriction enzyme will no 
longer recognize the site and will not cleave the fragment. The general procedure is to use a 
specific restriction enzyme to cleave DNA wherever the specified restriction site is located in the 
genome. These fragments can be separated and visualized through the use of gel electrophoresis 
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and Southern blotting. Polymorphisms can be detected through this technique if the size of one 
fragment differs from the others (Beckmann and Soller, 1983). Several studies using RFLPs have 
been performed to explore genetic diversity in swine populations. Yu et al. (1994) used RFLP's 
to study the association between economic traits and the PIT-1 gene, a pituitary transcription 
factor responsible for the activation of growth hormone in swine. Using RFLP’s, this study found 
associations between polymorphisms in the PIT-1 gene with carcass and performance traits, 
suggesting that PIT-1 was a candidate gene for a QTL for this trait. The biggest limitation of 
RFLPs is that this molecular technique can take a long time and requires several different 
cumbersome steps. Much like the use of alloenzymes, the laborious steps required for the use of 
RFLPs became overshadowed by the advent of PCR markers (Schlötterer, 2004).   
 PCR Markers: In the 1980s, a DNA amplification technique called Polymerase Chain 
Reaction (PCR) revolutionized DNA markers even further. PCR is a common tool that can make 
microgram quantities of billions of copies of a particular DNA segment by using primers (Singh 
and Singh, 2015). By amplifying a sample of a DNA segment, detection of polymorphisms is 
possible through the using primers as a marker. One of the marker types that utilizes PCR is the 
microsatellite. Microsatellites are repeats of DNA motifs and are highly polymorphic due to 
frequent mutations in these repeats. Microsatellites are abundant across the genome. These 
features of microsatellites allow scientists to create a DNA fingerprint that is unique to every 
individual (Nader et al., 2016). Analysis of DNA fingerprinting has led to several commercial 
applications, including paternity testing and identifying biological evidence in crime scenes. 
(Jobling and Gill, 2004). In a study specific to swine, microsatellites were used to study genetic 
variation between five populations of the Taihu pig (Fan et al., 2002). Using 27 microsatellites, 
they were able to confirm that Chinese pig breeds (Shawutou, Jiangquhai, and Dongchuan) and 
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European breeds (Large White, Landrace, and Duroc) belong to two divergent groups. While 
microsatellites have been successfully implemented in a wide variety of genetic and commercial 
applications, their biggest limitations were their high implementation cost and difficulties with 
studying unconventional model organisms.  
 Single Nucleotide Polymorphisms (SNPs): Alloenzymes, RFLPs, and PCR markers 
have been very useful in differentiating between allelic variants in proteins and DNA. The rise of 
DNA sequencing has, however, facilitated the discovery of single nucleotide polymorphisms 
(SNPs). SNPs can be defined simply as a polymorphism at a single base nucleotide at a specific 
position in the genome. SNPs can be located in non-coding and coding regions of the genome 
(SNP FAQ Archive, 2005). While the non-coding region does not produce protein through 
translation, products of non-coding regions or the sequences themselves have been found to 
participate in regulating transcription and translation. One study even indicated that SNPs in non-
coding regions are associated with various common diseases, such as cancer (Chu and Wei, 
2019). SNPs in non-coding regions that are found to be associated with a trait can also be used as 
a marker. They can be used for QTL detection, which is reliant on linkage disequilibrium (LD) 
between markers and a QTL, which is defined as the non-random association of alleles at 
different loci on the same chromosome in a population. (Mackay and Powell, 2007) 
SNPs that are located in protein-coding regions can be further divided into synonymous 
and non-synonymous SNPs. A synonymous SNP is one that does not change or affect the protein 
produced. This is because there are 64 possible combinations of the four nucleotides in a three-
base-pair codon (43 = 64) but there are only 20 encoded amino acids plus one codon for the 
termination of translation (Avise, 2014). This means that for many amino acids, different codons 
yield the same amino acid. Since SNPs are a substitution of a single base pair, translation of 
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different mRNA may incorporate the same amino acid, creating no change in the polypeptide 
chain. For this reason, synonymous SNPs are called silent mutations. Codon usage bias, which is 
defined as the differences in the frequencies of the occurrence of synonymous codons in coding 
DNA (Grantham et al., 1980), has been observed in several organisms, including humans (Hunt 
et al., 2009). While there are many synonymous codons that code for the same amino acid, there 
are optimal codons that an organism prefers for efficient translation of mRNA. This explains the 
potentially harmful effects of many silent mutations. Hunt et al. (2009) observed that silent 
mutations can affect the response of patients to various medications.  
Non-synonymous SNPs are polymorphisms that can directly change the amino acid 
sequence of a protein. This is the case where a single base pair change in a codon alters the 
amino acid that it encodes for, thus altering the structure and function of a protein (Hunt et al., 
2009). There are two types of non-synonymous SNPs: missense and nonsense. A missense SNP 
is a point mutation that changes the amino acid that the codon encodes for (Pal and Moult, 2015). 
Proteins are highly sensitive to these changes on the tertiary level, as the structure of a protein is 
heavily reliant on the spatial organization of hydrophobic and hydrophilic amino acids (Camiloni 
et al., 2016). Incorporating a different amino acid will often result in changes to protein folding, 
which can lead to the onset of genetic diseases, such as Crohn’s disease (Collij, 2019). A 
nonsense SNP on the other hand is a point mutation that creates a premature stop codon, 
terminating translation (Chu and Wei, 2019). This creates a truncated protein, which results in an 
incomplete and often nonfunctional protein product. 
The use of SNPs is advantageous over the use of other polymorphisms to measure DNA-
level variation because of their frequency and their ease of use. SNPs are abundant in the 
genome of animals, occurring on average once every 300 base pairs in the human genome 
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(Nelson et al., 2004). To date, millions of SNPs have been documented in humans, and their 
dense distribution across the genome allows them to be effectively used in genome-wide 
association studies (GWAS) to uncover genes associated with diseases. SNPs are often measured 
through the use of SNP panels, which are reliable tools due to them having a generally low 
genotype calling error rate (Ranade et al., 2001). Modern technology has facilitated high-
throughput analyses, enabling large scale population-level studies using a very large number of 
SNPs (Vignal et al., 2002). Also, SNPs are bi-allelic, which means there are only two allelic 
variants. This genetic characteristic of SNPs allows assaying of SNPs to be relatively easier than 
other DNA polymorphisms since the frequencies of each of the two alleles have a two-
component ratio (Foster et al., 2011). However, this also creates a limitation for SNPs because 
each marker will provide a relatively small amount of information. Thus, a considerably larger 
number of SNPs are required to identify associations with disease compared to using a more 
polymorphic genetic marker such as microsatellites. Another issue is that many high-throughput 
methods require expensive equipment. For non-model organisms without conventional SNP 
panels, the costs of genotyping and development of markers can be a limiting factor in the use of 
SNPs. Another limitation is that SNP discovery can introduce ascertainment bias (Nielsen et al., 
2000). This bias occurs in the development of SNP panels where SNPs with high frequency are 
often chosen over SNPs that are rare or if individuals are non-randomly selected. This bias can 
create problems when making inferences or associations with diseases if a rare SNP that was 
actually associated with a disease, was not included in the panel. However, ascertainment bias is 
not unique to just the use of SNP’s and is a problem in all experimental studies using a non-
random population. Despite these limitations, the benefits of SNPs far outweigh these 
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disadvantages. By utilizing SNPs, animal breeders can take advantage of LD in the form of 
genetic markers.    
Genetic Indicators 
A genetic indicator is a trait that is genetically correlated to a trait of interest. Several 
factors determine the success of a genetic indicator, in particular the following two requirements. 
First, the genetic indicator must be heritable. As previously discussed, if a trait is not heritable, 
selection on that trait will not result in genetic change in the population. The second requirement 
is that there must be a strong genetic correlation between the genetic indicator and the target 
trait. The presence of a genetic correlation between two traits usually implies that there is a 
pleiotropic relationship between the two traits, where the same genes affect both traits, in this 
case, the genetic indicator and the target trait. Both the genetic indicator and the trait of interest 
must also be measurable to be able to calculate a genetic correlation. It is also important to have 
a data acquisition system enabled to measure the wide phenotypic variation of both the genetic 
indicator trait and the trait of interest. This system should allow for the measurement of a genetic 
indicator trait on selection candidates, such as animals belonging to the nucleus herd. The 
recording cost should be low for a genetic indicator to be financially viable to a producer or a 
breeder. Last, it would be ideal for the genetic indicator to be measured early in life because they 
can provide information about the animal’s expected productivity, allowing producers or 
breeders to make decisions on which animals to keep. The use of genetic indicators that are 
measured early in life can reduce generation intervals since young animals can be used for 
selection as accurately as older animals (Schaeffer, 2006).  
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Major Swine Diseases 
A swine barn often harbors several multiple pathogens, ranging from bacteria to viruses 
to parasitic organisms. Several major swine pathogens play an influential role in the swine 
industry, including Porcine Reproductive and Respiratory Syndrome virus, Porcine Circovirus, 
Porcine Rotavirus, Porcine Parvovirus, as well as pathogens that cause coccidiosis and mastitis. 
In this section, three of these diseases will be discussed due to their relevance in the swine 
industry and because they were examples of viruses that were used the studies described in 
Chapters 3 and 4 of this thesis.  
 Porcine Reproductive and Respiratory Syndrome Virus: Porcine Reproductive and 
Respiratory Syndrome (PRRS) virus is an Arterivirus that costs the US Swine industry over 664 
million dollars each year (Holtkamp, 2013). In pregnant sows, the morbid impact of PRRS can 
cause stillborn piglets, mummified corpses, and abortions. Piglets that do survive past parturition 
often face a high rate of pre-weaning piglet mortality. PRRS is not limited to just sows and 
piglets, as the PRRS virus has been isolated before in semen from infected boars. Also, PRRS 
can cause severe respiratory problems in all pigs, resulting in weak and frail pigs. These pigs 
often do not eat and are unable to gain weight and thus, are unable to quickly reach market 
weight (Bøtner, 1997). In a swine production system, these sets of symptoms are a heavy 
economic detriment to the US swine industry.  
Detection of PRRS is difficult to achieve based solely on observable, clinical signs. 
Necropsies of pigs that have died to the PRRS virus have no physical lesions that are indicative 
of PRRS, except for lesions due to pneumonia (Rossow, 1998). Thus, serological testing is 
perhaps the most reliable and convenient method to detect for PRRS virus infection. The 
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pathogenesis of the PRRS virus is not completely clear. Initiation of PRRS virus infection is 
thought to originate from macrophage phagocytosis in the respiratory tract. The virus can 
replicate inside these cells and create symptoms, including, but not limited to, pneumonia, 
rhinitis, vasculitis, lymphadenopathy, and encephalitis (Rossow, 1998).  
Despite the major costs associated with PRRS, there is not yet an effective vaccine or 
medication with accepted widespread use. This is because there is a wide variety of genetically 
diverse strains of the PRRS virus. Also, previous studies have indicated that herds that have been 
vaccinated with a PRRS virus vaccine can be infected by a different strain of the virus. This 
suggests that due to the constant antigen shift of the PRRS virus, vaccination is ineffective 
against the PRRS virus (Kimman et al., 2009). In place of a PRRS vaccine, animal scientists 
have explored the use of genetic markers to select for increased disease resilience to PRRS. 
Boddicker et al. (2012) identified a major Quantitative Trait Loci (QTL) on Sus scrofa 
chromosome 4 (SSC4) that explained 15.7% and 11.2% of the genetic variance of viral load and 
weight gain in nursery pigs that underwent an experimental PRRS disease challenge. The QTL 
region of 0.5 Mb was found to be in high linkage disequilibrium (LD) and is tagged by the SNP 
WUR10000125 (WUR). In mammals, this region contains five Guanylate Binding Protein 
(GBP) genes, which have previously been observed to have strong effects on immune regulation 
and in mediating the inflammatory immune response in mice (Shenoy et al., 2012). Koltes et al. 
(2015) identified a splice site mutation in the GBP5 gene as the putative causative mutation for 
this QTL and found that that the WUR SNP was in complete LD with the GBP5 SNP. However, 
the latter conclusion was based on limited data from one genetic line. Literature on the effect of 
the SSC4 QTL is not limited to PRRS. Dunkelberger et al. (2017) observed that pigs co-infected 
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with both Porcine Circovirus Type 2b (PCV2b) and PRRS, but vaccinated for PRRS, had 
significantly lower viral load of PCV2b. 
 Porcine Circovirus 2: Another major infectious swine virus is Porcine Circovirus 2 
(PCV2). This is a small, nonenveloped virus of 17 nm in diameter that is commonly found in 
swine farms. Serological studies indicate that PCV2 infection is found worldwide, especially in 
regions with dense swine production (Segalés et al., 2005). This virus is associated with several 
other disease symptoms, including post weaning multisystemic wasting syndrome (PMWS), 
systemic disease, reproductive failures, respiratory problems, enteric diseases, and nephropathy 
syndrome (PDNS), which are collectively known as porcine circovirus associated diseases 
(PCVAD) (Segalés et al., 2005). PMWS is most observable in newly weaned piglets and is 
characterized by wasting, paleness, and respiratory distress (Segalés et al., 1998). Weaned piglets 
that are afflicted with PMWS may have the same observable symptoms as PRRS (Harding, 
2004). The most common symptom from PCV2 enteric disease (PCV2-ED) is constant diarrhea 
(Segalés et al., 2012). PCV2 reproductive disease (PCV2-RD) is characterized by abortions, 
mummifications, stillbirths, and reproductive failure at late gestation (Segalés et al., 2012). Last, 
PDNS is characterized by anorexia, depression, reluctance to move, and dark red papules on the 
pig's skin (Segalés et al., 2012). The most problematic, however, is arguably PMWS; Armstrong 
and Bishop (2004) estimated the cost of PMWS in the United Kingdom to be 35 million pounds 
per year. 
PCV was first detected and isolated from the pig kidney cell line PK-15 in a study that 
suggested that PCV is nonpathogenic (Tischer et al., 1974). However, a later study indicated that 
large quantities of the PCV antigen were observed within the lesions of piglets affected with 
PMWS (Clark and Harding, 1997). This inconsistency of the nature of PCV led to nucleotide 
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sequencing of two PCV isolates (Hamel et al., 1998), which determined that there were two 
different types of PCV: PCV type 1 and PCV type 2, where the latter was strongly associated 
with disease like PWMS (Hamel et al., 1998). Later studies suggested that pigs experimentally 
infected with a PCV2 inoculum rarely showed symptoms commonly seen in commercial swine 
herds (Bolin et al., 2001). Later studies explored this further and discovered that clinical 
symptoms only occur in pigs coinfected with another infectious agent (Allan et al., 1999). These 
studies indicate that PCV2 alone rarely causes disease (Segalés et al., 2012).  
PCV2 has a morbidity rate between 4 and 30% but this can increase to up to 60% in an 
epidemic. Mortality in affect farms ranges from 4 to 20% (Segales and Domingo, 2002). 
Diagnosis for PCV based on observational symptoms can be rather difficult because of the 
different clinical symptoms that PCV embodies. Also, due to the nature of PCV2, there must be a 
different diagnostic procedure for each of the PCVAD's, because the detection of antibodies or 
the presence of PCV2 does not identify the type of associated disease on the pig.  
Several vaccines are available to combat some of the diseases associated with PCV2. 
Most farms rely on a PCV2 vaccine to control PWMS in young piglets. Many studies have been 
done to evaluate the use of PCV2 vaccination and have found favorable results. Young et al. 
(2011) showed that PCV2 vaccination can improve production parameters such as average daily 
gain and body condition scores.  
 Porcine Influenza Virus: Swine influenza virus (SIV), sometimes called Swine Flu, is a 
type A influenza virus from the Orthomyxoviridae family (Doyle and Gordon, 2008). Symptoms 
from SIV include fever, coughing, nasal discharge, and weakness over the course of one week. 
While SIV has a high morbidity rate (Gramer et al., 2006) and can cause severe disease, it has a 
low mortality rate, indicating that swine farms infected with SIV can slowly recover (Richt, 
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2006). SIV can infect pigs of all ages but symptoms are most often seen in younger pigs. The 
pathogenesis of porcine influenza viruses has been well studied and indicates that the primary 
target for this virus is the respiratory epithelium cells (Van Poucke et al., 2010).  
All influenza viruses have major surface antigens comprised of hemagglutinin and 
neuraminidase glycoproteins (Gamblin and Skehel, 2010). The subtypes of influenza are based 
on the count of these glycoproteins. For example, classic SIV has one hemagglutinin and one 
neuraminidase glycoprotein, thus the nomenclature of classic SIV is HxNy; an example is 
pandemic H1N1. There are several different strains of swine influenza, including H2N2 and 
H1N2 (Crisci et al., 2013) that differ in the composition of these surface-level glycoproteins. 
These differences are created as a result of four main processes: antigen drift, antigenic shift, re-
assortment of genes in a concurrent infection with a different pathogen, or cross-species 
transmission (Diaz et al., 2013).  
Treatment for SIV is limited. Antiviral treatments are not licensed for use against SIV in 
commercial swine and, thus, vaccination is currently the main strategy for control of SIV. 
Unfortunately, there are many different strains of influenza virus and vaccination against one 
does not necessarily elicit protection against others (Vincent et al., 2008; Reeth et al., 2004). One 
strategy to mitigate the risk of SIV is relying on maternally derived antibodies by vaccinating 
breeding sows with an inactivated vaccine to stimulate passive antibody transfer to suckling pigs. 
This in turn reduces transmission of SIV between piglets (Romagosa et al., 2012). However, 
other studies have indicated that this strategy of using maternally derived antibodies has limited 
potential in preventing infection with swine influenza and may offer only partial protection 
(Cador et al., 2016). 
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Immune System 
Swine in commercial barns face a myriad of pathogens in their lifetime. The best way to 
protect pigs from pathogens is by quarantining the pigs from any source of pathogens. This is 
done for pigs in the nucleus herd, which are kept in rigorously biosecure units to minimize 
possible transmission of any swine disease. This is, however, not feasible for commercial swine 
herds. Pigs in commercial facilities are often faced with a wide variety of infectious swine 
pathogens. The role of the immune system is to protect the animal from pathogens that they may 
face in their lifetimes. The following section will review the mammalian immune system, in 
particular the innate and active immune response, and conclude with a discussion on disease 
tolerance, resistance, and resilience.  
The role of the immune system is to defend the body against harmful pathogens. There 
are two branches of the immune system (1) the innate immune system, and (2) the adaptive 
immune system. Innate immunity is sometimes called “non-specific immunity” while adaptive 
immunity is sometimes called “specific immunity”, as these two branches have different 
strategies for dealing with harmful pathogens. The innate immune system is very rapid and is the 
first line of defense against a pathogen. It is not selective, which means that it eliminates foreign 
invaders simply on recognizing whether the pathogen is of self or non-self. The adaptive immune 
system on the other hand, provides a slower response but results in a very specific response to a 
pathogen. The relationship between the innate and adaptive immune systems is that the 
immediate and broad innate response creates time for the slow, yet specific adaptive response to 
develop. When the adaptive immune response has been completed for a specific pathogen, the 
body has specialized mechanisms of ‘memory’ that allow an expedited response to that same 
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pathogen the next time it appears in the body. This section will discuss the main parts of the 
innate and adaptive immune systems.  
 Innate Immune System – Physical Barriers: The first external barrier to pathogens is 
the skin, which is not only the body’s largest organ but also the boundary between our bodies 
and the environment. The skin passively acts as a physical barrier that prevents pathogens from 
entering the body. Recent studies have shown that the skin is home to trillions of 
microorganisms, including commensal communities of microbiota that maintain a fundamental 
level of surface level protection from harmful microbes (Naik et al., 2015). However, cuts and 
wounds leave an opening in the skin that allow pathogens to enter. If left untreated, open wounds 
allow harmful pathogens to enter and cause direct damage to the animal. To prevent this, 
physical insults resulting in wounds will cause the body to undergo what is called the “cascade 
effect” which is a repair mechanism consisting of a series of steps that allow the body to repair 
the wound.  
While the skin is an effective physical barrier, many pathogens enter an animal’s body 
through food and water. A physical barrier that can protect an animal from ingested pathogens is 
the acidic condition created by acids in the stomach, which assist in chemically denaturing the 
majority of pathogens that find their way into an animal’s stomach. Some pathogens can enter 
the body through the air and make their way through nasal passages, trachea, and the urinary, 
urethral, and vaginal tracts. These routes, however, are lined with mucous, a type of sticky tissue 
that acts as another physical barrier. These sticky linings are produced by goblet cells that reside 
in mucosal membranes, and are particularly effective in trapping airborne pathogens in the nasal 
and trachea. In these passages, small tiny hairs called cilia can move mucous outside of the body 
in a wave like motion, and with it, the trapped pathogens. An enzyme called lysozyme is also 
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produced as part of the mucous, which helps destroy pathogens that are caught in the sticky 
lining.  
Innate Immune System – Cellular Components: When the three physical barriers are 
unable to keep a pathogen outside of the body, the organism’s cellular innate immune response 
will implement a series of steps to prevent replication and spread of the pathogen inside the 
body.  
The first step after an infection is the inflammatory response. The infection may cause 
tissue damage which causes mast cells to release a compound caused histamine. Histamine can 
then create two separate reactions, (1) vasodilation of local blood vessels and (2) increased local 
capillary permeability. Both of these reactions cause similar cardinal signs, such as redness, pain, 
swelling, and heat. The rate of blood flow to different parts of the body depends on the diameter 
of the blood vessels. Thus, dilation of the vessels by histamine reduces resistance and, thus, more 
blood flows into the area of infection. The greater blood flow also increases the delivery of 
healing factors, such as plasma proteins or clotting factors, which is important for infections 
caused by an opening in the skin. Histamine will also cause an increase in capillary permeability, 
which means that the pore size between the endothelial cells that form the walls of the capillary 
is increased. As a result, more fluid can accumulate in the area, which also includes the influx of 
macrophages. Macrophages and neutrophils are two types of leukocytes that the body 
implements heavily in the innate immune system. Neutrophils are the most abundant type of 
white blood cell in the body and are known for their mobility. They can easily move between 
vessels and tissues, quickly congregating in areas of the body that other cells cannot. Neutrophils 
are some of the first cells to arrive in an area of inflammation and will start the phagocytosis of 
any foreign invader, which is a nonspecific strategy for dealing with an infection. Similar to 
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neutrophils, macrophages will also implement phagocytosis of pathogens, but due to their large 
size, they often require histamines to expedite their travel to the inflammation site. Macrophages 
are also involved in cleaning up cell debris, such as dead neutrophils, which is important for 
resolving the inflammation.   
 Another type of cell that is specific to the innate immune response is the natural killer 
(NK) cell. The NK cells float freely in the body and are consistently on patrol for problematic 
cells. They are in charge of destroying cells infected or cancerous cells, based on an altered 
major histocompatibility complex (MHC), which are glycoproteins that are prominently 
displayed on surface of all cells. Hence, the name “natural killer” as a “non-natural” MHC of a 
cell automatically indicates to the NK cells that there is a problem with this cell, requiring no 
other activation for the NK cell to destroy the problematic cell. While NK cells are known for 
their use in the innate immune system, there is some recent evidence suggesting that NK cells 
also have a role in the adaptive immune response, and can develop antigen specific memory, a 
function of the adaptive immune response (Vivier et al., 2011).  
 Another part of the innate immune response is the interferons. Interferons are a large 
group of cytokines, which are chemical messengers the cell uses to communicate with other 
cells. While there are many documented roles of interferons, generally, they are chemical 
messengers that alert nearby cells of a viral infection. In other words, interferons will interfere 
with viruses. Take for example, a healthy cell that has now been infected with a virus. The virus 
requires another cell to survive, by taking over its machinery and replicating the virus DNA 
inside the host cell. While this happens, the infected cell will release interferons into the 
extracellular fluid, outside of the cell. These interferons travel and encounter surface receptors of 
other healthy cells, alerting them that a nearby cell has been infected with a virus. This causes 
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these alerted cells to heighten their viral defenses by creating a wide variety of inactivated 
enzymes. When a virus does infect those cells, the interferon induced enzymes will activate like 
a trap, effectively breaking down viral messenger RNA while reducing or even inhibiting viral 
protein synthesis. This means the virus can no longer replicate inside the cell.   
 Adaptive Immune System - Cell Mediated Immune Response:  The common 
mechanism of the innate immune system involves the removal of pathogens based on 
identification of self or non-self. While this method is fast, it is not efficient, as future infections 
of the same pathogen will likely require the same inflammatory response. The innate response 
does, however, provide time for the body to develop immunological memory against that 
specific pathogen. This is called the adaptive immune response and relies on use of antigens. An 
antigen can be defined as a unique molecule from the cell surface of a pathogen. It generally 
triggers an immune response in the body, which creates antibodies against it. The adaptive 
immune response can be separated into two responses: (1) cell mediated and (2) humoral.  
 The cell mediated immune response involves the cytotoxic T cell, which has the ability to 
release proteins called perforins when in the neighborhood of an infected cell, which increases 
the permeability of the infected cell, initiating it for apoptosis. This will inevitably destroy the 
cell. For viruses in particular, this means that the virus cannot replicate inside the cell, a 
requirement for virus survival. This behavior from the cytotoxic T cell is stimulated when it 
encounters an infected cell that has presented an antigen from the infectious agent, a process 
known as antigen presentation.  
Another type of T cell that is important for the adaptive immune response is the helper T 
cell. T helper cells often require the help from antigen presenting cells, such as macrophages 
which can phagocytize infected cells or pathogens without specificity, as previously discussed. 
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Macrophages can process the pathogen and present the pathogen’s antigen on its own surface, 
which can be presented to a T helper cells that has a matching receptor for the antigen. This leads 
into the humoral immune response.  
 Adaptive Immune System - Humoral Immune Response:  The humoral response 
involves the development of pathogen specific antibodies. When the T helper cell is activated by 
a matching antigen that is presented by a cell, it will wait until a B cell is also activated by the 
same antigen-T helper cell complex. When both the B and T cells are activated by the same 
antigen, this will cause the release of cytokines that induce that particular B cell to divide 
rapidly. The resulting cells are either plasma cells that release antibodies, or identical copies of 
the B cell, which are called memory B cells. This rapid division eventually causes the production 
of a large number of antibodies that are specific to that particular antigen, that are released into 
the bloodstream. Antibodies are Y shaped proteins that attach themselves to the binding site of 
any corresponding antigen found in the bloodstream. Since pathogens carry these antigens on the 
surface of the cell, antibodies will ultimately cover the surface of the pathogen by binding to the 
antigens. This binding can result in a myriad of different effects that impede the pathogen’s 
ability to cause damage. Antibodies can activate macrophages to instantly destroy pathogens that 
are covered in antibodies, or they can neutralize important parts of a pathogen that are necessary 
for it to replicate. Overall, the main goal of the adaptive immune response is to create antibodies 
that are specific to a pathogen’s antigen, which means the body will now be able to efficiently 
handle the same pathogen the next time it appears in the body.   
Disease resistance, resilience, and tolerance  
Animal breeders have a great interest in enhancing the overall immune responsiveness of 
the host animal. Disease occurs when environmental factors, such as the level of disease in a 
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swine barn, overwhelm a host animal’s genetic disposition to combat disease. One term 
commonly used is disease resistance, which can be defined as the animal’s ability to exert 
control over the pathogen’s life cycle (Bishop et al., 2012). Animals with high disease resistance 
can maintain productivity by limiting the replication of the pathogen. Therefore, animals that are 
highly resistant to a pathogen would have a lower pathogen burden, or amount of pathogen in the 
body. Pathogen burden can be quantified by using assays, such as Taqman PCR assays, which is 
what was used in the PRRS Host Genetics Consoritum (PHGC) trials to measure PRRS viral 
load in pigs (Boddicker at al., 2012). Disease tolerance, on the other hand, can be defined as the 
animal’s ability to minimize expression of disease on performance under an environment with a 
given level of pathogen burden (Bishop and Stear, 2003). One main challenge associated with 
measuring an individual animal’s resistance and tolerance is that pathogen burden within each 
animal needs to be measured at several key time points using precise assays. Disease resilience is 
a combination of disease tolerance and disease resistance and can be defined as the productivity 
of an animal during the course of an infection (Albers et al., 1987; Doeschl-Wilson et al., 2012; 
Mulder and Rashidi, 2017). Thus, resilient animals that are infected with disease are able to 
continue their productivity at a rate similar to non-infected animals.  
Tools to Evaluate Disease 
The mammalian immune system is complex. It consists of a network of organs that 
orchestrates a wide variety of cell-to-cell interactions and biological pathways in response to a 
pathogen. To investigate the biological manifestations of disease in an organism, one strategy is 
to analyze separate constituents of the immune system using an assay. Assays are laboratory 
tools that can be used to quantify the presence of a particular biomolecule, including the presence 
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of a pathogen. The following technologies are used to measure different components of an 
animal’s response to disease, with some of these used in the studies described in Chapters 3 and 
4.  
 Cell Flow Cytometry:  Cell flow cytometry is a widely used tool to sort and measure a 
sample of cells. This machine relies on the Coulter Counter, which was developed in the 1950s 
by Wallace H. Coulter and is used in almost every automated cell counter to this day. The basic 
objective of cell flow cytometry is to measure the physical properties of a cell as they flow 
through a microchannel. Named after Coulter himself, a Coulter Counter can measure the change 
in electrical impedance when a particle, such as a cell, is passed through a microchannel. 
Electrical impedance changes when the cell enters and leaves the channel, providing a reliable 
system to count cells. This technology was first successfully implemented to determine the 
composition of blood (Don, 2003). Today, modern cell flow cytometers can count thousands of 
cells all at once and can even be configured to sort cells with the addition of the dimension of 
optical physics to the Coulter Counter. This augmentation relies on the use of a laser to excite 
cells that pass through the channel. Each cell that passes through the laser will emit a special 
wavelength of light, which can be measured using a specialized sensor. Software can analyze 
these patterns, allowing information such as the size, surface characteristics, and 
immunophenotyping to be gathered. One study specific to swine has used cell flow cytometry to 
quantify T cells and to observe the rearrangement of immunoglobulin heavy chain genes 
(Sinkorava et al., 2019).  
 Quantifying the presence of a pathogen: There are many types of assays to identify the 
presence of a pathogen in a sample, two of which were used in the studies included this thesis. 
The first is the polymerase chain reaction (PCR) assay for the identification of pathogens. A PCR 
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assay allows the exponential amplification of a gene or a DNA fragment. These amplified 
products can then be separated on a gel using electrophoresis. This then allows for the 
identification of the pathogen. The second is a Fluorescent Assay, which uses a light source such 
as UV radiation to excite molecules in a sample. Initially, these molecules are at a ground state, 
but when hit with UV light, they will absorb light, which will be emitted when they return to a 
ground state. The wavelength and intensity of this emitted fluorescence can be detected and 
measured. The output of a fluorescent assay often includes vivid displays of color to visualize the 
location of targeted compounds, such as a pathogen. Johani et al. (2011) used fluorescently-
labeled antibodies to detect influenza virus in pigs. A third assay commonly used is the enzyme-
linked immunosorbent assay (ELISA). This assay can determine the presence of ligands, such as 
an antigen, in a sample. Antibodies that are linked to an enzyme, are mixed with a sample 
containing antigens. The critical step is that there must be a strong affinity between the antibody 
and the antigen, thus the reagents used are very important for success. Then, when the substrate 
for the enzyme is provided, an enzymatic reaction will occur, leading to a visual change in color. 
The presence of color indicates that the corresponding antigen to the provided antibody is present 
in the sample. Gamble et al. (1983) used ELISA to diagnose pigs with swine trichinosis.  
Mitogens 
Mitogens are chemical stimulants that are known to activate the proliferation of 
peripheral blood mononuclear cells and are commonly used in immunological experiments. 
Many mitogens are lectins, which are proteins that are derived from plants or bacteria (Mak and 
Saunders, 2006). Mitogens have a similar effect as antigens, can bind with receptors like 
antigens, resemble pathogen aggression, and trigger lymphocyte mitosis immediately after 
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recognition (Ko et al., 1979). Since mitogens can induce lymphocyte proliferation, they can be 
used to assess the responsiveness of an animal’s immune system to a potential pathogen. In two 
papers that previously utilized mitogen stimulation to measure immunity traits in swine, both the 
Edfors-Lilja (1994) and Flori (2011) group were able to measure lymphocyte by measuring DNA 
synthesis through the use of [3H]-thymidine during mitotic cell division. A scintillation beta-
counter was then used to measure the radioactivity of [3H]-thymidine incorporated into the DNA 
of the newly formed immune cells, providing both groups a direct measurement of mitotic cell 
division. In the following, the five mitogens that were used in the study described in Chapter 4 
will be described: Concanavalin A (Con A), Phytohemagglutinin (PHA), Poke Weed Mitogen 
(PWM), Lipopolysaccharide (LPS), and Phorbol myristate acetate (PMA). 
 Concanavalin A: Concanavalin A (Con A) is a tetrameric protein that is extracted from 
jack beans (Canavalia ensiformis). Also considered to be the most useful plant lectin, Con A has 
been shown to function as a T cell inducer. Con A works as a mitogen by binding to 
glycoproteins in the blood, particularly the T cell receptor (Kay 1991). One of the first mitogens 
to evaluate swine immunology was Con A, in a study in a study in which Con A induced 
immune cell proliferation was found to be correlated with other immune traits (Edfors-Lilja et 
al., 1994). Another study used Con A to study the blastogenic response of swine lymphocytes in 
blood and observed that Con A was successful in stimulating the peripheral blood mononuclear 
cells in pig blood, including T cells (Lin (2012). These studies suggest that Con A can be used to 
stimulate the pig's blood in vitro to observe immune proliferation.  
 Phytohemagglutinin: Phytohemagglutinin (PHA) is an extract from the kidney bean 
plant (Phaseolus vulgaris). PHA has been found to induce the proliferation of T cells (Mire-Sluis 
et al., 1987). Lamers (1999) used human blood to show that PHA can induce T lymphocyte 
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expansion. However, PHA is not limited to just T cell proliferation. Piguet et al. (1972) observed 
that PHA can induce B cell proliferation as well. These studies suggest that PHA can be used to 
study both T and B cell proliferation in swine.  
 Poke Weed Mitogen: Poke Weed Mitogen (PWM) is another plant lectin derived from 
the pokeweed plant (Phytolacca americana). PWM is commonly used as a stimulus to induce B 
cell differentiation in humans and rats (Blomgren et al., 2009 and Jørgensen et al., 1972). Paul et 
al. (1979) used pokeweed to stimulate blood lymphocytes in swine. Using immunofluorescence, 
they were able to detect the replication of both T and B cells. Another study found that PWM 
induces a wide variety of T cell subsets such as CD4 +, CD8 +, and gamma delta T cells (Dorn et 
al., 2002). These studies indicate that PWM is an effective mitogen for the stimulation of both B 
and T cells in swine. 
 Lipopolysaccharide: Lipopolysaccharide (LPS) is an endotoxin and is a major 
component of the outer membrane of gram-negative bacteria. It is important for structural 
integrity and the stabilization of the bacterial membrane (Rietschel et al., 1994). Since its 
discovery in the early 1900s, many studies have performed on the effect of LPS on the 
mammalian immune system. Schmitt et al. (2004) discovered that the body recognizes LPS due 
to a protein found on the surface of cells, which are named toll-like receptor 4 (TLR4). Once 
identified, the immune system will often react vigorously and immediately to an endotoxin such 
as LPS. Tough, et al. (1997) used LPS as a mitogen in mice and indicated that LPS can cause 
polyclonal activation of B cells and T cells. LPS was one of the mitogens used in the earlier 
studies of mitogen induced immune cell proliferation in swine (Flori et al., 2011). 
 Phorbol Myristate Acetate: Phorbol Myristate Acetate (PMA) is extracted from croton 
oil, obtained from the seeds of the croton tree (Croton tiglium). Similar to phytohemagglutinin in 
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effect, studies have shown that PMA can act as a mitogen as it stimulates T cell proliferation in 
humans (Touraine et al., 1977). One early study observed that PMA induces the proliferation of 
lymphocytes and affects glutamine metabolism in swine (Wu, 1996). Stepanova et al. (2012) 
showed that stimulation of whole blood cells from swine with PMA resulted in the proliferation 
of CD3+ and CD4+ T cells.  
Previous Mitogen Assay Studies in Pigs 
 The use of mitogens to evaluate of immune cell proliferation in swine has been 
performed before. One of the earliest studies estimated the genetic parameters of porcine 
immune traits, including Con A induced immune cell proliferation (Edfors-Lilja et al., 1994). 
Using blood extracted from 124 Yorkshire pigs of 8 weeks, the heritability estimates of Con A 
induced immune cell proliferation in-vitro was determined to be 0.38 +0.21 at 48 hours after 
stimulation with Con A at a concentration of 10 g/ml. This study also found positive 
phenotypic correlations of this trait with both interleukin-2 and IFN-alpha production in separate 
samples at 48 hours. Genetic correlations of immune traits with the Con A assay phenotypes 
were not determined. Another study used Con A, PMA, and LPS to estimate the genetic 
parameters of 32 immune traits, including mitogen-induced lymphocyte proliferation in-vitro, 
using blood samples collected on 443 Yorkshire pigs at eight weeks of age, three weeks after 
vaccination against Mycoplasma hyopneumoniae (Flori et al., 2011). This study found moderate 
estimates of heritability for the proliferation of immune cells at 48 hours post stimulation using 
Con A (0.36 +0.20), PMA (0.27 +0.20), and LPS (0.31 +0.19). However, these estimates were 
not significantly different from zero. The estimate of heritability of Con A was, however, 
consistent with the estimate of Edfors-Lilja et al. (1994), although both studies suffered from 
relatively large standard errors of heritability estimates. Flori et al. (2011) also reported very 
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small genetic correlations among these phenotypes and other immune related traits, with large 
standard errors.  
Gao et al. (2010) used DNA microarrays in a transcriptome analysis to observe the 
proliferation of porcine PBMCs when stimulated with LPS and a mixture of PMA and 
ionomycin for 24 hours. This study showed that stimulation with these two mitogens yielded 
distinct immune responses, which was verified by the activation of different sets of genes. 
However, the genes that were activated after stimulation with either mitogen shared the top 
biological functions in catalogs from Diseases and Disorders, Molecular and Cellular Functions, 
and Physiological System Development and Function, which suggested that the effects of the 
two stimulants were broadly similar (Gao et al., 2010). However, it was found that the relative 
representation of each biological function differed between the two mitogens. For LPS, the most 
represented genes were related to Disease and Disorder, while for PMA and ionomycin, the most 
represented genes were related to Molecular and Cellular functions.  
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Abstract 
A genomic region on chromosome 4 that is tagged by single nucleotide polymorphism (SNP) 
WUR0000125 (WUR) was previously found to be associated with host response to porcine 
reproductive and respiratory syndrome (PRRS) virus infection. The objectives of this study were 
to 1) determine whether genotype at the WUR SNP is also associated with resilience to a natural 
polymicrobial disease challenge, 2) investigate the relationship of genotype at the WUR SNP 
with genotype at its putative causative mutation in the GBP5 gene, and 3) compare the  
 
1Department of Animal Science, Iowa State University, Ames, IA, USA. 
2 Hendrix Genetics, Swine Business Unit, Boxmeer, The Netherlands. 
3Department of Large Animal Clinical Sciences, University of Saskatchewan, Saskatoon, SK, Canada. 
4Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, AB, 
Canada. 
5Centre de développement du porc du Québec inc. (CDPQ), Québec City, QC, Canada. 
6USDA, ARS, BARC, APDL, Beltsville, Maryland 
7Department of Diagnostic Medicine and Pathobiology, Kansas State University, Manhattan, KS, USA 
8PigGen Canada, Guelph, ON, Canada. 
 
42 
 
association of the WUR and GBP5 SNPs with host response to PRRS virus (PRRSV) infection. 
Data from two studies were used: 1) Eight trials of the PRRS Host Genetic Consortium (PHGC), 
in which ~200 naïve crossbred nursery pigs/trial were infected with the NVSL-97-7895 strain of 
PRRSV to study the effects of genotype at the GBP5 and WUR SNPs on viral load and weight 
gain post-infection; 2) a natural disease challenge, where 3139 naïve crossbred nursery barrows 
were entered into a grow-finish facility that was seeded with multiple pathogens to maximize 
expression of disease resilience. Results from the PHGC trials showed that the WUR and GBP5 
SNPs are in high but not complete linkage disequilibrium (r2=0.94). A haplotype analysis 
showed that discordant genotypes between the WUR and GBP5 SNPs were due to genetic 
recombination and not the result of genotyping errors. We were unable to determine whether 
GBP5 or WUR had a stronger effect on phenotype. Results from the natural disease challenge 
indicated that the favorable allele for the WUR SNP was significantly associated with greater 
average daily gain (p=0.02) and lower numbers of treatments in the challenge nursery (p=0.05) 
and across the nursery and finisher (p=0.01). Therefore, swine breeders can continue to use the 
WUR SNP not only as a marker for resilience to PRRSV infection, but also as a marker for 
disease resilience to a polymicrobial disease challenge.   
Introduction 
 Infectious disease has large economic costs in the swine industry and affects animal 
welfare. One such disease is Porcine Reproductive and Respiratory Syndrome (PRRS), caused 
by the PRRS virus (Holtkamp et al., 2013). The PRRS virus (PRRSV) affects both young pigs 
and pregnant sows. Infected young pigs show respiratory symptoms such as pneumonia, fever, 
and lethargy, while infected pregnant sows can have abortions or give birth to dead or 
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mummified piglets (Holtkamp et al., 2010). The total cost to the United States swine industry 
was estimated to be around 664 million US dollars per year (Holtkamp et al., 2013). The PRRSV 
can mutate rapidly, allowing a great variety of PRRSV strains to exist, which reduces the 
effectiveness of preventative vaccines and medications (Fang et al., 2007).  
One strategy to mitigate costs due to PRRS and other infectious porcine diseases is to 
genetically select animals with higher disease resilience, which is defined as the ability to 
maintain relatively undiminished performance levels under infection (Albers et al., 1987; 
Doeschl-Wilson et al., 2012; Mulder and Rashidi, 2017). However, direct selection of disease 
resilience is difficult because the elite nucleus populations that genetic selection is practiced in 
must be kept under biosecure conditions. An alternative approach is to select on genetic markers 
that are predictive of disease resilience, as this can be practiced in high-health nucleus herds. 
Previous research has shown that the Sus scrofa chromosome (SSC) 4 contains a 
Quantitative Trait Locus (QTL) for host response to PRRSV infection (Boddicker et al., 2012). 
Single Nucleotide Polymorphisms (SNPs) in this QTL region of 0.5 Mb were in high linkage 
disequilibrium (LD) in the breeds and crosses investigated by Boddicker et al. (2012, 2014) and 
the region was tagged by the single nucleotide polymorphism (SNP) WUR10000125 (WUR). In 
pigs, this QTL region contains five Guanylate Binding Protein (GBP) genes, which are 
recognized for their effects on immune regulation and for mediating inflammatory immune 
response in the mouse (Shenoy et al., 2012). Koltes et al. (2015) identified a splice site mutation 
in the GBP5 gene as the putative causative mutation for this QTL and showed that the WUR 
SNP is in complete LD with the GBP5 SNP. However, the LD result was based on limited data 
from one genetic line. Literature on the effect of this QTL are not limited to PRRS. Dunkelberger 
et al. (2017) showed that the WUR SNP is also associated with porcine circovirus 2b (PCV2b) 
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viral load following co-infection with PRRSV and PCV2b of pigs that were vaccinated for 
PRRS, although Kreikemeier et al. (2015) did not identify the SSC4 QTL region to be associated 
with PCV2b viremia in pigs that were only infected with PCV2b. In commercial production, pigs 
are typically exposed to multiple pathogens and, thus, it is also important to evaluate the effect of 
the SSC4 QTL on disease resilience under a polymicrobial disease challenge. 
To further investigate the effects of the WUR SNP and the putative causative mutation in 
the GBP5 gene, three objectives were pursued here: 1) determine whether the SSC4 QTL (the 
WUR SNP) is associated with resilience to a polymicrobial disease challenge in pigs, 2) 
investigate the LD of the WUR SNP with its putative causative mutation in the GBP5 gene in 
different genetic lines, and 3) compare the association of the WUR SNP versus that of the 
putative causative mutation in the GBP5 gene with host response to a PRRSV infection.  
Materials and Methods 
Porcine Reproductive and Respiratory Virus (PRRSV) Infection Trials 
Animals and data 
To investigate the relationship between and effects of genotype at the WUR SNP and the 
putative causative mutation in the GBP5 gene, data from the first eight trials of the PRRS Host 
Genetics Consortium (PHGC) (Lunney et al., 2011) were used. The animal experiments for the 
PHGC were approved by the Institutional Animal Care and Use Committee of Kansas State 
University. Detailed accounts of the design and data collection in the PHGC trials are in Lunney 
et al. (2011) and Boddicker et al. (2012, 2014). Briefly, data were available from eight batches of 
about 200 high-health commercial crossbred pigs, which were transported after weaning to 
Kansas State University, where each batch was subjected to an experimental PRRSV challenge. 
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Pigs from the first three batches came from the same breeding company but each batch after that 
came from a different company (Boddicker et al., 2014). After a one-week acclimation, all pigs 
were experimentally infected (intranasal and intramuscular) with the NVSL-97-7895 strain of the 
PRRSV. Blood samples were collected at -6, 0, 4, 7, 14, 21, 28, 35, and 42 days post-infection 
(dpi) and all pigs were euthanized at 42 dpi. Viremia was measured using a TaqMan PCR assay 
for PRRSV RNA. Viral load was calculated for pigs that had viremia records on day 0 and at 
least 5 other days, as the area under the curve of log2-transformed viremia at 0, 6, 7, 11, 14, and 
21 dpi. Body weights were collected at 0, 7, 14, 21, 28, 35, and 42 dpi. Weight gain was 
calculated as body weight at day 42 minus day 0, except for pigs that died before 42 dpi, as 
detailed by Boddicker et al. (2012). All pigs were genotyped with Illumina’s Porcine SNP60 
BeadChip (San Diego, CA), which includes the WUR SNP but not the GBP5 SNP. Thus, all pigs 
were also genotyped separately for the GBP5 SNP, using a custom Sequenom panel (Geneseek 
Inc.). 
Statistical Analyses 
Linkage disequilibrium between the WUR and GBP5 SNPs was calculated as the 
correlation between the genotypes at the WUR and GBP5 SNPs, both within and across the eight 
trials. For WUR, the three genotypes were AA, AG, and GG, where G is the favorable allele. For 
GBP5, the three genotypes were GG, GT, and TT, where T is the favorable allele. With complete 
LD, the genotype at WUR should match the genotype at GBP5 exactly.  
In order to determine if discordant genotypes between these two markers were due to 
genotyping errors or genetic recombination, the Haploview software (Barrett et al., 2005) was 
used to identify the haplotypes that were present within the 1 Mb region across the trials and the 
frequency of each haplotype. In order to determine discordant genotypes were the result of 
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genotyping errors, a preliminary analysis was done to see if changing the allele at either marker 
matched another haplotype with a reasonable frequency. In order to determine if a discordant 
haplotype was due to a single recombination event between GBP5 and WUR, each discordant 
haplotype was investigated to see if recombining two non-discordant haplotypes would yield the 
discordant haplotype in question. Finally, pedigree information (sire and dam) was used to 
determine whether pigs with the same discordant haplotype within a genetic source had a 
common parent. If the pigs that carry a discordant haplotype within a trial shared a parent, this 
indicates that the parent carried that haplotype, and therefore, the discordant genotype at the two 
markers are not due to genotyping error, but due to genetic recombination. If there was not a 
common parent, the genomic relationship (computed in Hess et al., 2018) between pairs of 
discordant pigs was evaluated. 
The effects of genotype at the WUR and GBP5 SNPs on PRRSV viral load and weight 
gain were evaluated by fitting them separately as fixed effects in a linear mixed model with 
additional fixed effects of trial, parity of the sow within trial, and sex, the covariates of initial age 
and weight, and the random effects of pen within trial, litter, and animal genetic effects. To 
determine which SNP had a stronger association with phenotype, both SNPs were fitted 
simultaneously in the model and significance of adding the GBP5 (WUR) SNP when the WUR 
(GBP5) SNP is already in the model was evaluated in ASReml 4.0 (Gilmour et al., 2009). 
Significance was declared at P  0.05, with suggestive significance at p<0.10. 
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Natural Disease Challenge Model 
Animals and protocols 
Data from the natural disease challenge described by Putz et al. (2019) were used to 
investigate the effect of the WUR SNP on response to a severe polymicrobial challenge. The 
natural disease challenge enabled the expression of disease resilience related phenotypes, 
facilitating the recording of these traits. The natural disease challenge was carried out in 
accordance with the Canadian Council on Animal Care guidelines 
(CCAC; https://www.ccac.ca/en/certification/about-certification) and was approved by the 
Protection Committee of the Centre de Recherche en Sciences Animales de Deschambault 
(CRSAD) and the Animal Care and Use Committee at the University of 
Alberta (AUP00002227). The project was conducted and overseen by the Centre de 
développement du porc du Québec (CDPQ) and the herd veterinarian, along with project 
veterinarians. The CDPQ research facility was equipped with tools and staff that allowed for 
detailed phenotype recording, blood sampling, and strict biosecurity. Collection of the data used 
started in late 2015 and concluded in early 2019. 
 A detailed overview of the design, data collection, and genotyping for the natural disease 
challenge is in Putz et al. (2019).  Briefly, the CDPQ facility was segmented into three physical 
compartments: (1) a separate quarantine nursery, where the crossbred (Landrace and Yorkshire 
F1 barrow) piglets were kept for around 19 days after weaning from a high-health multiplier and 
transported to the facility; (2) a challenge nursery, where the naïve piglets were subjected to the 
disease challenge for around 28 days; (3) a finishing unit, where the pigs were raised to slaughter 
weight for 69 days on average. Every three weeks, a new batch of 60 or 75 naïve piglets was 
introduced in the quarantine nursery, alternating between the seven member genetics companies 
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of the PigGen Canada consortium. For the current study, data from the first 50 batches were 
used. 
The polymicrobial challenge was established using seeder pigs, which were naturally 
infected pigs that were obtained from farms in the area, and were introduced together with the 
first four batches of naïve pigs to replicate diseases that occur in commercial barns. After 
inoculation of the challenge nursery, each new batch of naïve piglets was allowed fence-line 
contact with the previous batch for ~1 week to maintain the disease challenge, circumventing the 
need for labor-intensive re-inoculation of the challenge nursery. To maintain controlled disease 
pressure and acceptable levels of mortality that were instituted by the Animal Protection 
Committee, licensed veterinarians closely monitored the health of every batch through 
established veterinary protocols, including removal of fence-line contact to infect the new batch 
of pigs when the disease pressure became too high. After the first seven batches vaccination for 
PCV2 was added to the quarantine protocol. Pigs were treated from a list of 10 antibiotics, as 
needed, depending on their individually expressed clinical symptoms. Preventative mass 
treatments were also given through the drinking water, usually by batch. Decisions to euthanize 
pigs were by farm staff, based on defined endponts, with oversight from licensed veterinarians. 
 The following viruses were identified in the challenge nursery during the study: three 
strains of PRRSV, two strains of Swine Influenza Virus, PCV2, and Porcine Rotavirus A. 
Bacterial pathogens identified included Actinobacillus pleuropneumoniae, M. hyo, Streptoccus 
suis, Haemophilus parasuis, Brachyspira hampsonii, Salmonella sp., Cystoisopora suis, 
Erysipelothrix rhusiopathiae, and Staphylococcus hyicus. This list of bacterial pathogens is not 
comprehensive and several other minor bacterial pathogens that were not identified may have 
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been present. In addition, not all bacterial pathogens were found in every batch, reflecting the 
heterogeneity and dynamics of disease pressure in commercial farms.  
Data Collection 
The phenotypic data that were collected on all pigs in the natural disease challenge were 
described in detail in Putz et al. (2019). In addition to identification of the pig’s dam, and the 
quarantine, nursery, and finisher pen it was in, information collected on each pig included date of 
birth, age at weaning, and whether or not they received pen enrichment (non-edible toys) in the 
quarantine and challenge nursery (used for half of the pens of batches 41 to 50), as part of a 
separate study to evaluate the impact of environmental enrichment on resilience.  Individual 
body weights were recorded, starting with entry into the quarantine nursery, at entry and at exit 
of the challenge nursery, and every three weeks thereafter in the finisher. Pigs that were severely 
diseased were weighed more often. For the calculation of average daily gain (ADG), LOESS 
predicted daily weights were used, as described by Putz et al. (2019). Groups of pigs were sent to 
slaughter every three weeks. Pigs from a batch that had not met the targeted market weight of 
135 kg were delayed from slaughter for three weeks. Carcass traits that were recorded at the 
slaughter house included back fat, loin depth, and lean yield. 
 Feed was available ad libitum throughout the two nursery and finisher units. Individual 
feed intake was measured and quantified in the finisher, as described by Putz et al. (2019), 
resulting in a daily total for each animal for the amount of feed consumed (kg) and time spent in 
the feeder (duration in minutes).  Feed intake traits evaluated included Average Daily Feed 
Intake (ADFI), Feed Conversion Ratio (FCR), and Residual Feed Intake (RFI), as described by 
Putz et al. (2019). Only pigs that survived to slaughter were analyzed for these traits. Several 
novel disease resilience phenotypes were derived from the daily feed intake data by Putz et al. 
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(2019), including the proportion of off-feed days and day-to-day variation in feed intake. The 
proportion of off-feed days was based on the proportion of days with a negative residual from 
5% quantile regression of feed intake or duration on age across pigs, as described by Putz et al. 
(2019). Pigs with a higher proportion of off-feed days were considered less resilient than those 
with a smaller proportion of off-feed days. Day-to-day variation in feed intake was based on the 
root mean square error for daily feed intake or duration of ordinary least squares regression of 
feed intake or duration on age by pig, as described by Putz et al. (2019). Similar to proportion of 
off-feed days, pigs with a higher day-to-day variation in feed intake were expected to be less 
resilient than those with a smaller day-to-day variation in feed intake.  
 Treatments and mortalities were recorded by CDPQ staff. The number of treatments was 
a count of the total number of individual treatments that a pig received, which included any drug 
injection, but excluded group and batch level treatments. Clinical symptoms that were recorded 
included abscesses, arthritis, ataxia, black scours, conjunctivitis, diamond skin disease, digestive 
or respiratory problems, fever, greasy pig disease, grey or brown diarrhea, inappetence, 
lameness, problems with locomotion, convulsions, nasal discharge, cyanosis, rectal prolapse, 
dysentery, thumping, mites, sneezing, tail/ear/flank biting, and salmonella. To account for the 
smaller number of days at risk for pigs that died prematurely, the number of treatments was 
scaled to a standard length of 180 days for number of treatments to average age at slaughter, to 
27 days for number of treatments in the challenge nursery, and to 100 days for number of 
treatments in the finisher. For pigs to have a record of treatments scaled to 180, they were 
required to reach 65 days of age. The number of treatments for respiratory symptoms was also 
analyzed in order to focus on treatments for PRRS. Mortality was also measured as a phenotype, 
identifying pigs that died in the challenge nursery, the finisher, or across both phases.  
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All pigs were genotyped using a commercial 650K SNP panel (Affymetrix), consisting of 
658,692 SNPs, including the WUR SNP, but not the GBP5 SNP. Details on the genotyping, 
filtering, and imputation of missing genotypes are in Putz et al. (2019). 
Statistical Analyses 
Data from the 3,126 pigs that were entered into the natural challenge facility in 50 
batches were analyzed using a univariate linear mixed model that included the fixed effects of 
batch, entry age (covariate), and WUR genotype, and pen, sow, and animal genetics as random 
effects. Previous studies have shown that the G allele at the WUR SNP is rare in most 
commercial lines and that the G allele appears to be completely dominant over the A allele in its 
effects on host response to PRRSV infection (Boddicker et al., 2014). Therefore, pigs with at 
least one G allele were grouped and contrasts were calculated between genotypes AA and 
[AG+GG]. Significance was declared at P  0.05, with suggestive significance at P<0.10. To 
incorporate animal genetic effects, a genomic relationship matrix was constructed from the SNP 
genotypes, with relationships between pigs from different companies set to 0. Mortality in the 
challenge nursery, the finisher pen, and across the nursery and finisher were also analyzed as 
continuous traits. For carcass traits, pre-slaughter weight, slaughter age, and slaughter date were 
added as covariates. All analyses were conducted using the lme4qtl package in R (Ziyatdinov et 
al, 2018).   
Results and Discussion 
Linkage disequilibrium between WUR and GBP5 
Koltes et al. (2015) determined that the WUR SNP was in complete LD with the putative 
causative mutation in the GBP5 gene (r2 = 1) based on genotypes of 58 boars from a commercial 
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Yorkshire line of pigs, to such that the WUR SNP is an effective marker to select for improved  
host response to PRRS. Our more comprehensive analysis, using genotype data of 1387 pigs 
from PHGC trials 1 to 8, however, found the LD between these two markers to be incomplete, 
with r2 = 0.94. The LD between the two SNPs ranged from 0.72 to 0.99 for pigs from the 
individual companies that contributed to the PHGC trials. Table 3.1 displays the counts of 
genotypes of all 1387 pigs from the 8 PHGC trials, while genotype counts for each trial are in 
Supplementary Table 3.1. In total 43 of the 1387 animals had discordant genotypes (off-
diagonals in Table 3.1), for which the genotype at the WUR SNP did not match the genotype at 
the GBP5 SNP. The large majority of these were AG at WUR and GG at GBP5; however, all 
pigs with the GG genotype at WUR matched the TT genotype at GBP5.  
In order to determine whether the mismatches between the genotype at the WUR and 
GBP5 SNPs were due to genotyping errors or to recombination events, a haplotype analysis was 
conducted. Across all trials, 135 unique haplotypes were observed for the 1 Mb region around 
the WUR and GBP5 SNPs, consisting of 47 SNP’s. This window was narrowed down to 13 
SNPs, with the WUR and GBP5 SNPs at the 5th and 9th position respectively, yielding 18 unique 
haplotypes across the 13 SNP region. Among these 18 haplotypes, three had discordant alleles at 
the GBP5 and WUR SNPs. Each of these 3 haplotypes could be generated through a single 
recombination event between the GBP5 and WUR SNPs for two concordant haplotypes. Based 
on pedigree analysis, every pig that had a discordant genotype within a trial, shared at least one 
parent with another pig from that trial with the same discordant haplotype, except for one pair of 
pigs. The genomic relationship between these two pigs was, however, 0.45, suggesting that they 
shared a recent common ancestor that likely carried the discordant haplotype. Overall, the 
haplotype analysis provides substantial evidence that the discrepant genotypes were due to 
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recombination events, rather than genotyping errors. The recombination frequency between these 
the WUR and GBP5 SNPs could, however, not be determined since the number of meiosis 
events was not available. 
Effects of WUR and GBP5 on host response to PRRSV infection 
Results in Table 3.2 show that estimates of the effects of the WUR and GBP5 SNPs on 
weight gain and viral load following PRRSV infection were similar but not identical, because of 
the incomplete LD. Because the GBP5 SNP is the putative causative mutation, it was expected to 
exhibit a stronger association with host response than the WUR SNP. However, when fitting 
both SNPs simultaneously, the p-value for the extra variation explained by the GBP5 SNP, after 
the WUR SNP was already included, was not significant (p=0.46 for VL and p=0.23 for WG), 
suggesting that there is no statistical evidence that the GBP5 SNP was more strongly associated 
with host response to PRRS than the WUR SNP. Because differences between the effects of the 
two SNPs were small, if not zero, the WUR SNP, which is present on most commercial SNP 
panels, can continue to be used to select for improved host response to PRRS. However, the LD 
between these two SNPs should continue to be monitored in each breeding population. 
Effect of WUR genotype on disease resilience traits 
Genotype counts for the WUR SNP for pigs in the natural disease challenge are in Table 
3.3. Of the 3126 pigs evaluated, only 25 pigs were homozygous for the favorable allele (GG), 
consistent with the low frequency of the G allele in the populations evaluated by Boddicker et al. 
(2014b). Because of these small numbers and indications from Boddicker et al. (2014b) that the 
G allele shows complete dominance for host response to PRRS, animals with the GG genotype 
were combined with heterozygous animals for genetic analyses. Results in Table 3.4 show that 
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pigs with at least one G allele at the WUR SNP had better performance for a number of traits 
related to disease resilience. Pigs with at least one G allele were found to have significantly 
higher challenge nursery average daily gain (p = 0.02) and fewer health treatments (p = 0.05, 
0.22, and 0.01 for treatments in the challenge nursery, the finisher, and across the challenge 
nursery and finisher, respectively), demonstrating that pigs with the favorable WUR genotypes 
have higher resilience to a polymicrobial disease challenge. While the effect of WUR genotype 
was not statistically significant for all traits, numerically, all traits were found to follow the 
expected trend, with pigs with at least one G allele at the WUR SNP having a more beneficial 
phenotype. To determine whether most of these effects were the result of PRRS, treatments 
specific to respiratory problems were analyzed separately. Resulting p-values for the effect of 
WUR genotype on numbers of respiratory treatments were, however, not significant (p = 0.66, 
0.26, and 0.54 for treatments in the challenge nursery, the finisher, and across the challenge 
nursery and finisher, respectively).  
Because pigs that are sick are not expected to eat as much as those that are healthy, feed 
intake under challenge is expected to reflect resilience to disease. Previous studies on the 
relationship of feed intake with disease resilience include results from Putz et al. (2019), using 
part of the data used here, who showed that day to day variation in feed intake, feed intake 
duration, and in the proportion of off-feed days were genetically correlated to mortality and 
treatment rates under disease. The health of the animal can affect carcass traits as well, as pigs 
that are not consuming as much feed during the challenge phase are expected to have smaller 
carcass size. In addition, non-resilient pigs are expected to expend more energy on combating 
disease rather than gaining weight, therefore, the results in Table 3.4 reflect the pig’s disease 
resilience ability based on their genotype at the WUR marker. 
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Conclusions 
In conclusion, swine producers can benefit from selection on genotype at the WUR 
marker. Although the genotype at the WUR marker is not completely consistent with genotype at 
the putative causative mutation in the GBP5 gene, differences of the effects of these two SNPs 
on host response to PRRSV infection were small and not statistically significant. Thus, the WUR 
SNP, which is present on most commercial SNP panels, can continue to be used to select for 
improved host response to PRRS. The WUR SNP was also found to be favorably associated with 
disease resilience in a polymicrobial disease challenge. Pigs with at least one favorable allele had 
higher growth rate under challenge, fewer health treatments, and a tendency for lower mortality.  
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Table 3.1: Concordance (counts) of genotypes at the WUR and GBP5 genetic markers in the 
combined PHGC trials 1 to 8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
WUR genotype
GBP5  Genotype AA AG GG
GG 1011 4 0
GT 6 285 0
TT 1 32 46
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Table 3.2: Least squares means (SE) for viral load and weight gain by genotype at the WUR and 
GBP5 markers based on data from the PRRS infection trials. 
  
  
Genotype (number of favorable alleles)   
Trait Marker 0 1 2 
p 
Value 
            
Viral Load1 WUR 107.72 (0.90) 103.43 (0.97) 104.98 (1.37) <0.001 
  GBP5 107.58 (0.89) 103.07 (0.96) 104.26 (1.20) <0.001 
            
Weight Gain2 WUR 14.00 (0.47) 15.94 (0.50) 15.46 (0.74) <0.001 
  GBP5 14.09 (0.47) 16.05 (0.51) 15.43 (0.65) <0.001 
 
1 area under the curve of log2(viremia) from 0 to 21 days post infection 
2 weight gain from 0 to 42 days post infection (kg) 
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Table 3.3: Frequency of genotypes at the WUR marker for pigs in the natural disease challenge. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Genotype Count Frequency 
AA 2699 0.863 
AG 402 0.129 
GG 25 0.008 
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Table 3.4: Estimates of the effect of genotype at the WUR SNP (AG+GG versus AA) on 
response to a polymicrobial disease challenge. 
Trait Number of records Mean (SD) 
Estimate of 
contrast 
(AG/GG)-AA 
P-value of 
contrast 
Average daily gain (g/day) in:     
          Quarantine nursery 3196 280 (0.09) -1.2 0.76 
          Challenge nursery 3176 295 (0.18) 18.4 0.02 
          Finisher 2337 897 (0.13) 8.7 0.26 
Average daily feed intake (g/day) 
 
2337 2202 (0.32) 27.5 0.15 
Feed conversion ratio (g/g) 2336 2578 (0.20) 13.4 0.26 
Residual Feed Intake (g/day) 2336 0.30 (0.13) -7.0 0.31 
Back fat thickness (mm) 2048 17.3 (3.8) 0.2 0.16 
Loin depth (mm) 2050 60.2 (6.14) 0.3 0.29 
Off-feed days, Duration (%) 2337 0.04 (0.04) -0.004 0.58 
Off-feed days, Feed Intake (%) 2337 0.04 (0.05) -0.004 0.20 
Day-day variation, Duration (min/day) 2337 13.33 (3.78) 0.01 0.11 
Day-day variation, Feed Intake (g/day) 2337 501 (0.10) -5.4 0.39 
Lean yield (%) 2045 60.1 (1.71) -0.2 0.27 
Mortality (%) in:     
Challenge nursery 3186 11.4% -4.1 0.23 
Finisher 2829 16.1% -1.8 0.55 
Nursery + finisher 3205 26.3% -4.3 0.24 
Number of health treatments in:     
      Challenge nursery (27 days) 3098 1.16 (1.21) -0.21 0.05 
      Finisher (100 days) 2295 0.33 (0.62) -0.06 0.22 
      Nursery + Finisher (180 days) 2295 1.39 (1.33) -0.18 0.01 
Number of respiratory treatments in:     
      Challenge nursery (27 days) 3098 0.55 (0.77) -0.14 0.66 
      Finisher (100 days) 2292 0.23 (0.59) -0.11 0.26 
      Nursery + Finisher (180 days) 2295 0.36 (0.55) -0.10 0.54 
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Supplementary Table 3.1: Frequency of genotypes at the WUR and GBP5 SNPs in PHGC 
trials 1 to 8 by genetic source 
                                 
                                  
WUR 
GBP5 AA AG GG 
Trials 1, 2, 3 
n=508  
GG 364 - - 
GT 1 125 - 
TT - 1 15 
Trial 4  
n=195 
GG 159 - - 
GT - 20 - 
TT - 2 4 
Trial 5 
n=195 
GG 134 - - 
GT - 50 - 
TT - 5 4 
Trial 6 
n=125 
GG 113 4 - 
GT - 1 - 
TT 1 1 - 
Trial 7 
n=192 
GG 84 - - 
GT - 65 - 
TT - 19 23 
Trial 8  
n=190 
GG 157 - - 
GT 5 24 - 
TT - 4 - 
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Disease resilience refers to productivity of an animal under disease challenge. Given the 
high biosecurity of pig nucleus herds, traits that can be measured on healthy pigs and that are 
genetically correlated with disease resilience, i.e. genetic indicator traits, offer a strategy to select 
for disease resilience. Our objective was to evaluate mitogen stimulation assays on peripheral 
blood mononuclear cells from young healthy pigs as genetic indicators for disease resilience. 
Data were from a natural disease challenge in which batches of 60 or 75 naïve Yorkshire x 
Landrace piglets were introduced every three weeks into a continuous flow barn that was seeded 
with multiple diseases. Disease resilience traits, including growth, feed intake, and treatment and 
mortality rates, were recorded on 3136 pigs that were genotyped for 650K SNPs. Peripheral 
blood mononuclear cells isolated from whole blood collected prior to pathogen challenge from 
882 of these pigs from 19 batches were stimulated with five mitogens: concanavalin A (ConA), 
phytohemagglutinin (PHA), pokeweed mitogen (PWM), lipopolysaccharide (LPS), and phorbol 
myristate acetate (PMA), and evaluated for counts of proliferated cells after 48, 72, and 96 hrs 
compared to unstimulated samples (Rest Count). Heritabilities of cell proliferation were 
estimated using a model with batch as a fixed effect, along with the covariates of entry age, Rest 
Count, and complete blood count proportions of lymphocytes, monocytes, eosinophils, and 
basophils, and pen, litter, and animal (with genomic relationships) as random effects. Heritability 
estimates were highest for ConA (0.29, 0.25, 0.13, and 0.23 at 48, 72, and 96 hrs, and for area 
under the curve across the three time points, respectively) and were in a similar range for PHA 
and PMA, but low for PWM and LPS. ConA, PHA, and PMA had moderately high estimates of 
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genetic correlations with several disease resilience traits that were generally in the expected 
direction but were not significantly different from zero due to large standard errors. In 
conclusion, although validation is needed, mitogen stimulation assays, in particular based on 
ConA, show promise as a genetic indicator trait for disease resilience. 
 
Introduction 
Infectious disease remains a substantial problem in the United States swine industry. One 
such disease is porcine reproductive and respiratory syndrome (PRRS), which is estimated to 
cost the United States swine industry 664 million US dollars each year (Holtkamp et al., 2013). 
PRRS is commonly found in swine barns globally and can cause severe reproductive disease, 
interstitial pneumonia and immune suppression enhancing secondary infections. Porcine 
circovirus associated disease (PCVAD) was estimated to cost the British swine industry £52.6 
million per year prior to the availability of a vaccine in 2008. In addition to  PCVAD and PRRS, 
there are many other viral, bacterial and parasitic pathogens affecting commercial pig 
production. Common and influential pathogens in the North American industry include 
Mycoplasma hyopneumoniae, swine influenza virus, porcine rotavirus, porcine epidemic diarrhea 
virus, Escherichia coli, Lawsonia intracellularis, Streptococcus suis, Brachyspira 
hyodysenteriae and Ascaris suum.  
A genetic indicator is a trait that is genetically correlated to a trait of interest. A genetic 
indicator for disease resilience would be a trait that can be measured in the nucleus without 
infecting the nucleus herd. The two main requirements for a genetic indicator are that it be 
heritable and it must have a strong genetic correlation with the target trait. One possible class of 
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genetic indicators for disease resilience is mitogen stimulation assays (MSAs), which are based 
on the proliferation of peripheral blood mononuclear cells (PBMCs) following stimulation with a 
mitogen. Mitogens have a similar effect as antigens, resembling pathogen exposure and 
triggering lymphocyte mitosis immediately after recognition (Ko et al., 1979). Proliferation of 
PBMCs following mitogen stimulation can be assessed in-vitro to quantify cell-mediated 
immune response reflecting the potential of an animal's immune response when exposed to 
infectious pathogens. In the early 2000s, a Disease Resistance Assay for Animals (DRAA) was 
developed for pigs and evaluated by Pharmagap Inc. (Ottawa, Canada) in conjunction with the 
Atlantic Swine Research Partnership Inc. and the Canadian Centre for Swine Improvement 
(CCSI). Although this assay, which was based on stimulation of PBMCs with five mitogens, was 
never fully validated or made commercially available, significant differences in the immune 
capacity were reported (Hurnik et al., 2006). In this present study, the same five mitogens were 
used to stimulate PBMCs isolated from blood of nursery pigs prior to their exposure to a 
polymicrobial challenge: 1) concanavalin A (ConA), 2) phytohemagglutinin (PHA), 3) 
pokeweed mitogen (PWM), 4) lipopolysaccharide, and 5) phorbol myristate acetate (PMA). 
ConA has previously been documented to activate T-lymphocyte division in swine (Lin, 2012), 
while PHA has been found to activate T-lymphocyte mitosis in rats and humans (Lamers et al., 
1999; Piguet et al., 1972), by activating the same subsets of T-lymphocytes as ConA. PWM and 
PMA are both plant-based mitogens that are known to activate both B- and T-lymphocytes in 
swine (Paul, et al., 1979; Stepanova et al., 2012). Lastly, LPS is an endotoxin present in all 
Gram-negative bacteria that acts as a potent stimulator of the innate immune system, and has 
been shown to activate B-lymphocytes in a wide variety of mammals (Tough, et al., 1997).  
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 Mitogen stimulation assays have been used to measure the genetic basis of porcine 
immune cell proliferation in two previous studies. Edfors-Lilja et al. (1994) used blood extracted 
from 124 Yorkshire pigs at 8 weeks of age and reported the heritability of ConA induced 
immune cell proliferation in-vitro at 48 hours to be 0.38 +0.21. A similar study was performed 
by the Flori et al. (2011) but with an expanded set of mitogens including ConA, PMA, and LPS, 
on blood from 443 Yorkshire pigs at 8 weeks of age, 3 weeks after vaccination against M. 
hyopneumoniae. They estimated the heritability of immune cell proliferation in response to 
ConA, PMA, and LPS at 48 hours to be 0.36 +0.20, 0.27 +0.20, and 0.31 +0.19.  
This study aimed to determine whether MSAs can be used to derive genetic indicators for 
resilience to polymicrobial disease by estimating 1) the heritability of immune cell proliferation 
following mitogen stimulation, and 2) phenotypic and genetic correlations among immune cell 
proliferation assays and with disease resilience traits. Samples and data from a large-scale natural 
polymicrobial disease challenge study of grow-finish pigs (Putz et al., 2019) were used for this 
study. 
Materials and Methods 
Natural Disease Challenge Model 
This study was carried out in accordance with the Canadian Council on Animal Care 
guidelines (CCAC; https://www.ccac.ca/en/certification/about-certification). The protocol was 
approved by the Protection Committee of the Centre de Recherche en Sciences Animales de 
Deschambault (CRSAD) and the Animal Care and Use Committee at the University of 
Alberta (AUP00002227). The project was fully conducted at and overseen by the Centre de 
développement du porc du Québec (CDPQ) and the herd veterinarian together with project 
veterinarians. The CDPQ research facility is equipped with tools and staff that allows for 
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detailed phenotype recording, blood sampling, and strict biosecurity. Data collection for this 
study started in late 2015 and concluded in early 2019. 
The natural disease challenge study consisted of three phases (Putz et al., 2019): (1) a 
separate quarantine nursery, where the weaned piglets were first placed for around 19 days; (2) a 
challenge nursery, where the naïve piglets were placed for around 28 days after quarantine and 
first exposed to disease challenge; (3) an adjoining grow-finishing unit, where the pigs recovered 
from challenge and were raised until slaughter for on average 100 days. Every three weeks, a 
new batch of 60 or 75 naïve Yorkshire x Landrace barrows was introduced in the quarantine 
nursery, alternating between seven members of the PigGen Canada consortium. These pigs were 
considered naïve, with minimal exposure to disease. After three weeks in the quarantine nursery, 
the batch of naïve piglets entered into the challenge nursery for 4 weeks, where they were 
exposed to various pathogens commonly found in commercial swine barns, before entry into the 
finishing unit. The various pathogens in the natural disease challenge were first established in the 
barn by introducing infected pigs from nearby farms. Natural disease challenge was maintained 
through fence line contact of pigs from the new batch with pigs from the previous batch in the 
challenge nursery. The following viruses were identified in the challenge farm (nursery and 
grow-finish combined): three strains of the PRRS virus, two serotypes of swine influenza virus, 
porcine circovirus type 2, and porcine rotavirus A. Bacterial pathogens identified included 
Mycoplasma hyopneumoniae, Streptoccus suis, Glasserella (Haemophilus) parasuis, 
Brachyspira hampsonii, Salmonella spp., Erysipelothrix rhusiopathiae, and Staphylococcus 
hyicus. By using natural transmission of common swine pathogens, the natural disease challenge 
replicated a severe diseased environment in a commercial swine barn. The data used here are 
from 3139 piglets that were entered the natural disease challenge in 50 batches. All pigs were 
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genotyped using a commercial 650K SNP panel (Affymetrix), consisting of 658,692 single 
nucleotide polymorphisms. For more details on the genotyping and imputation of missing 
genotypes, see Putz et al. (2019). 
Mitogen Stimulation Assays  
Blood samples used for the MSA were collected in the quarantine nursery, before entry 
into the challenge nursery, on randomly chosen pigs from batches 13 to 38, for a total of 882 pigs 
across 18 batches. For batches 13 to 24, blood samples were collected at ~27 days of age, 6 days 
after arrival in the quarantine nursery. For logistical reasons, for batches 25 to 38, blood samples 
were collected at ~41 days of age. Complete Blood Count (CBC) data were available on all pigs 
from blood samples collected at ~27 days of age, as described by Bai et al. (2020). Blood was 
collected by CDPQ staff in 10 mL vacutainer sodium salt heparinized tubes placed immediately 
on crushed ice and transported on ice packs to the University of Laval on the same day. PBMCs 
were purified from the samples on the same day, by gradient centrifugation in 50 mL conical 
tubes at 400 × g for 10 min to remove the plasma, followed by mixing 1:1 in Hank’s balanced 
salt solution (HBSS) and 12 mL of lymphocyte separation medium (Wisent Inc., St-Bruno, 
Québec, Canada, #cat: 305-010-CL), then centrifugation at 600 × g for 30 min. The PBMC rings 
were then transferred into a new 50 mL conical tube with a pasteur pipet and diluted by adding 
40 mL of HBSS before centrifugation at 400 × g for 10 min. The cell pellets were gently 
suspended in 2 mL NH4Cl solution for 5 min at 37 ℃ to lyse contaminated erythrocytes. Lysis 
was stopped by adding 20 mL of HBSS and centrifugation at 400 × g for 10 min. Each PBMC 
sample was then resuspended in 5 mL RPMI1640 (Wisent Inc., St-Bruno, Québec, Canada, #cat: 
350045036). Cells were enumerated by using the Trypan blue exclusion procedure (Rao and 
Otto, 1992). PBMCs were then diluted to a final concentration of 1.33 × 105 cells/mL in 
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complete RPMI1640 containing 10% of decomplemented exosomes free fetal bovine serum 
(FBS) (Sigma-Aldrich, St. Louis, MO), glutamine, non-essential amino acids, sodium pyruvate 
and penicillin/streptomycin (Wisent Inc., St-Bruno, Québec, Canada). The culture was then 
maintained in a CO2 incubator (5%) at 37 oC in a humidified atmosphere.  
For the MSA, five mitogens (ConA, PHA, PWM, LPS, and PMA) were strategically 
chosen to evaluate the proliferation capability of different types of immune cells 
(Supplementary Table 4.1). The readout of the assay was based on fluorometric estimation of 
total DNA content of cell populations, which is directly related to the number of cells in the 
assayed population (Strober et al., 2001). PBMCs were plated in 96 well plates (Costar round 
bottom) at 20,000 cells/well/150 µl, each row containing PBMCs from one pig. The first and the 
last rows were empty cells used for background or positive DNA control measurement. The five 
mitogens were added to PBMCs in columns 7 to 12 at a 4x concentration in 50 µL of complete 
RPMI. PBMCs in columns 1 to 6 were used as technical replicates for resting or unstimulated 
cells, by adding 50 µL of complete RPMI. For each sample (columns 1-6), there were six wells 
for Rest Count and six wells for a mitogen at a specific time point, resulting in six technical 
replicates per animal per mitogen per time point. The plates were then incubated at 37 oC in 5% 
of CO2 for 48, 72 or 96 hrs. After incubation, the number of cells was quantified by DNA 
estimation using the Hoechst reagent and a fluorescence plate reader. The 96 well plates were 
centrifugated for 5 min at 400 × g and the supernatant gently aspirated. The cells were rinsed 
twice with 200 µL PBS containing Ca++ 0.8 mM and Mg++ 0.8 mM, before centrifugation. Cells 
were lysed by adding 100 µL lysis buffer (0.02% SDS in 1X SSC) to each well, except for eight 
wells in rows 1 and 8, which were reserved for the DNA standard and Blank (four wells each). 
The plates were then incubated at 37 0C for 1 h with occasional swirling. Then, 100 µL of 40 
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µg/mL DNA were added to the four DNA standard wells and 100 µL of 1X SSC buffer to the 
four blank wells in rows 1 and 8. Then 100 µL of 4 µg/mL Hoechst 33258 reagent in 1X SSC 
buffer were added to each well. The plate was then incubated on gently agitation at room 
temperature for 5 min and protected from light by wrapping in aluminum foil, after which the 
plates could be stored at -70 0C for a few days. Fluorescence intensity was measured at an 
excitation wavelength of 355 nm and an emission wavelength of 460 nm or close wavelength 
depending on the instrument (here Cytofluor, Millipore or Galaxy, BMG labs) Tecan instrument.  
Disease Resilience Traits 
Disease resilience traits evaluated in the natural disease challenge were average daily 
gain in the challenge nursery (cNurADG) and in the finisher (FinADG), number of treatments in 
the challenge nursery (NurTRT), in the finisher (FinTRT), and across the challenge nursery and 
finisher (ALLTRT), mortality in the challenge nursery (NurMOR), in the finisher (FinMOR), 
and across the nursery and finisher (ALLMOR). Treatments and mortalities were recorded by 
CDPQ staff. The number of treatments was a count of the total number of individual treatments 
that a pig received, which included any drug administered intramuscularly by injection, but 
excluded group- and batch-level treatments administered via water, feed or parenteral 
administration. To account for the smaller number of days at risk for pigs that died, the number 
of treatments was scaled to a standard length of 180 days for number of treatments to average 
age at slaughter, to 27 days for number of treatments in the challenge nursery, and to 100 days 
for number of treatments in the finisher. Mortality was also measured as a phenotype for pigs 
that died in the challenge nursery, the finisher, or across both, with “0” for pigs that survived 
until the end of that phase, and “1” for pigs that died prior the completing the phase. Subjective 
health scores were assigned to each pig by trained personnel at four time points: at 5 days after 
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entry into the quarantine nursery (qHScore1, at ~26 days of age); 19 days after entry into the 
quarantine nursery (QHScore 2, at ~41 days of age); two weeks after entry into the challenge 
nursery (cHScore); and six weeks after entry into the finisher (FinHScore). Scores were assigned 
on a scale of 1 (severe clinical symptoms of disease) to 5 (healthy condition). For more details on 
the scoring system, please refer to Cheng et al. (2020). 
For the finishing traits, FinADG, FinTRT, and ALLTRT, two sets of phenotypes were 
analyzed. The first set consisted of data on pigs that survived to slaughter (survival data). The 
second set (expanded data) also included phenotypes on some pigs that died prior to slaughter in 
the finisher by imputation and expansion of their incomplete phenotypes, as described by Cheng 
et al. (2020). Only incomplete records that were reliably imputed (based on weight > 0.75, see 
Cheng et al. (2020)), were included.   
Statistical Analyses 
For the MSA, two methods were used to adjust cell counts from the stimulated wells for 
each pig and each mitogen at each time point for cell counts in the unstimulated wells at that 
time point: 1) Blastogenic Index Score (BIS) computed by dividing the average cell count of the 
stimulated wells by the average cell count of the non-stimulated well, and 2) by including the 
average cell count of the non-stimulated wells as a covariate in the model for analysis of the 
average cell count of the stimulated wells. A BIS score greater than one indicates greater cell 
proliferation, while a BIS score less than one indicates greater cell death (Han and Dadey, 1978). 
Data obtained using both approaches were edited by removing extreme outliers, being those that 
were more than three times the standard deviation away from the mean of the dataset. In total, 
292 out of 1320 individual data points were removed for BIS and 171 out of 1320 individual 
points for stimulated means. After outlier removal, each mitogen at each time point was checked 
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for normality. Distributions of the BIS and stimulated means data were skewed to the right and, 
therefore, a log2 transformation was applied prior to analyses.  
Data across the three time points were also combined into an Area Under the Curve 
(AUC) for pigs and mitogens for which all three time points were available. The AUC for each 
pig and each mitogen was calculated by fitting a quadratic function to log-transformed BIS or 
stimulated mean data by regression analysis and integrating the resulting quadratic function 
between 48 and 96 hours. For the AUC for stimulated means, the stimulated mean at each time 
point was first adjusted for Rest Count based on the estimate of the covariate from the statistical 
model described in the following. Changes in log-transformed BIS or adjusted stimulated means 
between time points (deltas) were also computed and analyzed for each mitogen (delta = 72 – 48 
hrs, 96 – 72 hrs, and 96 – 48 hrs).  
 The following univariate model was used to estimate the heritability of BIS for each 
mitogen at each time point, using ASReml 4.0 (Gilmour et al., 2009):  
Yijklm = μ + Batchj + b1* Agei + b2*Lymphocytesi + b3*Monocytesi + b4*Eosinophilsi + 
b5*Basophilsi + Animali + Sowk + Penl(j) + Platem(j) + eijklm  
where Yijklm = the log2(BIS) for animal i for a given mitogen at a given time point;  
Batch = fixed effect of batch; Age = the age at entry into the quarantine nursery; Lymphocytes, 
Monocytes, Eosinophils, Basophils = the proportion of each immune cell type from the CBC 
data; Animal = random animal genetic effect of the ith individual, assumed distributed ~N(0, 
Gσg
2), with G equal to the genomic relationship matrix constructed using SNP genotypes, with 
pigs from different companies assumed unrelated, and σg
2 equal to the genetic variance; Sow = 
sow or litter effect; Pen = random effect of pen nested within Batch (50 levels); Plate = random 
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effect of plate nested within batch (146 levels); e = residual. For analysis of the Stimulated Mean 
data, the log2-transformed cell count of non-stimulated wells was added to the model as a 
covariate. Proportions of cell types from the CBC data were used as covariates to account for any 
possible impact of cell proportions on the MSA. Although none of the covariates were 
significant, they were conservatively left in the model because they only took up 4 degrees of 
freedom. Fitting separate covariates for MSA conducted on blood collected at ~27 versus ~41 
days of age, with CBC always taken at the ~27 day time point, did not result in significant 
differences and, therefore, only one covariate per cell type was fitted in the final model. The 
proportion of neutrophils and of ‘large unidentified cells’, as obtained from the CBC data, were 
not included in the model because the proportion of neutrophils was highly correlated with the 
proportion of lymphocytes (r=0.91), while the ‘large unidentified cells’ were determined to be 
mostly agglutinated cells. The univariate analyses were used to estimate the narrow sense 
heritability (h2) for each MSA trait, as well as variance due litter effects as a proportion of 
phenotypic variance (c2). Phenotypic variance was estimated as the sum of estimates of variances 
due to animal genetics, sow, and residuals. 
Bivariate analyses were conducted to obtain four sets of genetic and phenotypic 
correlations. The first set consisted of correlations between the BIS and the corresponding 
stimulated mean phenotypes, to evaluate the impact of the two approaches to account for Rest 
Count. The second set consisted of correlations between time points and the AUC for the same 
mitogen for both the BIS and stimulated mean data. The third set consisted of correlations among 
different mitogens at the same time point and the AUC for both the BIS and stimulated mean 
data. The fourth set estimated consisted of genetic and phenotypic correlations of the MSA traits 
with each of the disease resilience traits evaluated. Correlations were estimated using bivariate 
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models in ASReml 4.0, using the model described above for the MSA traits and models 
described in Cheng et al. (2020) for disease resilience traits. For the latter, resilience data from 
all 3139 pigs across 50 batches were used, using their genomic relationships with pigs with MSA 
data. 
The first set of correlations could not be estimated using ASReml 4.0 (no convergence) 
and were, instead, estimated by analyzing the sum of BIS and stimulated mean as a phenotype. 
For these analyses, the stimulated mean data were adjusted for the covariate Rest Count using the 
regression coefficient that was obtained from the univariate analysis of each trait. The sum of 
each BIS phenotype with its corresponding adjusted stimulated mean phenotype was then 
analyzed as a single trait using the univariate model described above to estimate its phenotypic 
and genetic variance. The covariance (genetic or phenotypic) between the BIS and stimulated 
mean phenotypes was then estimated by rearranging the formula of a sum as:  
Var(BIS + Stimmean) = Var(BIS) + Var(StimMean) + 2Cov(BIS, StimMean) 
Cov(BIS, StimMean) =
Var(BIS + StimMean) − Var(BIS) − Var(StimMean)
2
 
Estimates of genetic and phenotypic variances for the individual phenotypes were as obtained 
from the univariate analyses. 
Results 
Basic Statistics of MSA Data 
Descriptive statistics of the MSA assay results are presented in Table 4.1. For resting cell 
count, ConA showed a general increase from 48 to 96 hrs. This proliferation in unstimulated 
cells is unexpected, since growth factors in the blood sample are in limited supply. For the other 
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four mitogens, the average resting cell count either went down or was relatively stable between 
48 and 96 hours, as expected, since cells expend energy to maintain homeostasis in a resting 
state. For the stimulated wells, there were large numerical changes and observable patterns 
between 48 and 96 hrs. For PWM, the largest mean cell count was at 48 hrs, while for ConA, the 
largest count was at 72 hrs. For PHA, LPS, and PMA, the largest count was at 96 hrs. This 
variety in trends between mitogens becomes more complex when considering the changes 
between two individual time points. The within-sample coefficient of variation was between 13 
and 17% for the resting cell counts but generally higher, up to 29% for the stimulated cell counts.  
Descriptive statistics of the log-transformed BIS scores and stimulated mean phenotypes 
are presented in Table 4.2. The means of the stimulated mean data were fairly similar across the 
five mitogens, ranging from 12.0 to 12.7 for individual time points, from 1671 to 1759 for AUC, 
and from -0.4 to 0.2 for individual deltas. This pattern of consistency was not evident for BIS 
scores. Notably, the means for individual time points and for AUC were substantially larger for 
ConA, PHA, and PMA than for PWM and LPS. In addition, for each mitogen, the largest 
average BIS was at 72 hrs. 
Heritability of MSA Phenotypes 
Heritability for each MSA phenotype was estimated for each mitogen for both the BIS 
and stimulated mean data and are shown in Table 4.2. In general, estimates of heritability were 
numerically very similar for BIS and stimulated means and, therefore, only estimates for BIS 
will be discussed in the remainder of this section. Estimates of litter effects were all very small 
for all MSA phenotypes (Table 4.2), with most values being zero, suggesting that the 
environment provided by the sow had very limited impact on the MSA phenotypes.  
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Estimates of heritability at individual time points were moderately high (0.19 to 0.28) for 
ConA and PHA at all three time points and for PMA at 72 hrs (0.29) but low for PWM and LPS 
across all time points (<0.10) and for PMA at 48 (0.12) and 96 hrs (0.04). For all mitogens, with 
the exception of LPS, the largest estimate of heritability was at 72 hrs. This pattern was 
consistent with the largest BIS scores being at 72 hrs for most mitogens.  
Heritability estimates for AUC were similar to the highest estimate across time points for 
each mitogen, except for PHA, for which the estimate of heritability of AUC was higher than at 
any of the three individual time points. The delta phenotypes showed no clear patterns in 
heritability estimates. For ConA, PWM, and PMA, change from 48 to 72 hrs had heritability 
estimates that were higher or as high as the most heritable individual time point. Estimates of 
heritabilities for most other delta phenotypes were as large as or smaller than for individual time 
points.    
Correlations between BIS and Stimulated Mean Phenotypes 
Estimates of genetic and phenotypic correlations between BIS and their corresponding 
simulated mean phenotypes are in Table 4.2. These estimates provide insight into the effect of 
these two methods of accounting for the count of unstimulated wells. Because of lack of 
convergence of estimates with ASReml, these correlations were calculated based on an alternate 
method that does not restrict estimates to the parameter space, resulting in some estimates to be 
greater than 1. In general, estimates of phenotypic correlations between BIS and the 
corresponding stimulated mean phenotypes were high, whereas estimates of genetic correlations 
were also high but very variable, reflecting the large standard errors for estimates of genetic 
correlations. The average estimates of genetic correlations between the BIS and corresponding 
stimulated mean phenotypes within a mitogen were 0.86, 1.11, 0.67, 1.27, and 1.20 for ConA, 
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PHA, PWM, LPS, and PMA, respectively. These high genetic correlations suggest that selecting 
on either BIS or stimulated mean would have similar effects.  
Correlations Among Time Points within the Same Mitogen 
Estimates of genetic correlations between time points and the AUC for the same mitogen 
are in Table 4.3, while corresponding phenotypic correlations are in Supplementary Table 4.2. 
For both the BIS and stimulated mean phenotypes, the magnitude of all estimated genetic 
correlations was found to be positive. Some estimates were large, but all estimates had 
substantial standard errors. When considering these large standard errors, it is notable that for 
ConA and PHA, estimates based on BIS were similar to corresponding estimates based on 
stimulated means for each pair of time points. This was as expected, as the BIS and stimulated 
mean phenotypes were found to have high genetic correlations (Table 4.2).    
Correlations Among Mitogens at the Same Time Point 
Estimates of genetic among mitogens at the same time point are in Table 4.3 and 
corresponding phenotypic correlations in Supplementary Table 3.3. Similar to the genetic 
correlations among time points within the same mitogen, several genetic correlations could not 
be estimated, especially those that involved PWM and LPS phenotypes. All estimated genetic 
correlations were positive and some were some high positive ( > 0.90), but with large standard 
errors. When considering the standard errors, genetic correlation estimates between mitogens 
based on BIS were similar to those based on stimulated mean. Genetic correlation estimates 
between ConA and PHA for corresponding MSA phenotypes were consistently strong, which 
was as expected since these two mitogens activate similar cell types.  
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Correlations of MSA with Disease Resilience Traits 
Descriptive statistics of the evaluated performance and resilience traits are in Cheng et al. 
(2020). Reasons for treatments and mortalities and their frequencies are summarized in 
Supplementary Table 4.4. Infection and disease were responsible for nearly all of the 
prescribed treatments and mortalities causes. Respiratory distress accounted for 956 (27.9%) of 
treatment reasons and 187 (19.2%) of mortality reasons. Non-infectious causes only accounted 
for a small portion of reasons.  
Estimates of genetic correlations of MSA phenotypes with disease resilience traits are in 
Figure 4.1 and corresponding phenotypic correlations are in Supplementary Tables 4.5 for BIS 
and in Supplementary Table 4.6 for stimulated means. Heat maps displaying genetic and 
phenotypic correlations of MSA phenotypes with disease resilience traits are in Supplementary 
Figure 4.2. Estimates of phenotypic correlations were low, suggesting limited opportunities to 
predict the resilience of an individual pig based on its MSA phenotypes. For genetic correlations, 
estimates are only presented for ConA, PHA, and PMA because the low heritabilities for PWM 
and LPS resulted in genetic correlation estimates with very large standard errors or could not be 
estimated. Even the estimates for the ConA, PHA, and PMA had large standard errors and none 
were statistically significantly different from 0 (p>0.05) based on the likelihood ratio test (King, 
2020). Nevertheless, several MSA phenotypes showed consistent trends in estimates across time 
points and across resilience traits in the expected direction, and are described in more detail 
below. For the finisher traits, estimates of genetic correlations were fairly similar between the 
survival and expanded data (Supplementary Figure 4.1). Therefore, only estimates for the 
survival data will be described in the following.  
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 Growth rate: Estimates of genetic correlations of BIS phenotypes with growth rate in the 
quarantine nursery (qNurADG), the challenge nursery (cNurADG), and in the finisher (FinADG) 
are shown in Figure 4.1. The overall trend of estimates genetic correlations with growth rate in 
the quarantine nursery was found to be ambivalent. Associations of MSA phenotypes with 
growth rate in the quarantine nursery were expected to be weak since the expression of disease is 
expected to be minimal at this stage. Some genetic correlation estimates with qNurADG differed 
substantially when based on BIS versus stimulated mean data, e.g. ConA and PHA at 48 hrs, 72 
hrs, and 96 hrs. Additionally, estimates for ConA were positive at each time points based on BIS 
but negative when based on stimulated mean. Standard errors were large. Estimates with AUC 
were negative but weak for all three mitogens. Genetic correlation estimates with deltas were 
mostly positive but generally weak.   
Estimates of genetic correlations with growth rate in the challenge nursery were positive, 
as expected, for ConA and PMA phenotypes at individuals time points and AUC. Corresponding 
estimates for PHA were weak and variable in sign. The delta phenotypes had weak and variable 
genetic correlation estimates with cNurADG. Differences between estimates based on BIS versus 
stimulated means were generally small, except for PHA at 48 hrs and for ConA for delta 96–48.  
Estimates of genetic correlations of MSA phenotypes at individual time points and for 
AUC with growth rate in the finisher were generally weak. Genetic correlations with AUC based 
on stimulated means could not be estimated. Estimates of genetic correlations of FinADG with 
the delta MSA phenotypes were positive for delta 72-48 and delta 96-72, but negative for delta 
96-48. PMA phenotypes had the strongest estimates of genetic correlations with FinADG among 
the three mitogens, but with large standard errors. Differences between estimates based on BIS 
and stimulated means were minimal, except for PMA at 72 hrs and 96 hrs. Genetic correlations 
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with growth rate in the finisher were also estimated using pigs from the expanded dataset 
(Supplementary Figure 4.1). Generally, differences between estimates obtained using the 
survivor and expanded datasets were minimal.  
 Treatment Rates: Estimates of genetic correlations with numbers of treatments in the 
challenge nursery were generally negative for MSA phenotypes at individual time points and for 
AUC. For the delta MSA phenotypes, genetic correlation estimates were consistently negative 
for all three mitogens. Differences between estimates based on BIS and stimulated means were 
small, except for PMA at 48 hrs and 96 hrs, for which the sign of the estimate differed between 
the two.  
 The majority of genetic correlations with number of treatments in the finisher could not 
be estimated because the heritability of this resilience trait was very small. Correlations that 
could be estimated had extremely high standard errors and showed no clear trend. Estimates of 
genetic correlations of the number of treatments across the challenge nursery and finisher with 
MSA phenotypes generally followed similar trends as observed for treatments in the challenge 
nursery. However, the patterns observed for the delta phenotypes for number of treatments in the 
nursery were not evident across the nursery and finisher. Genetic correlations for number of 
treatments in the finisher and across the challenge nursery and finisher were also estimated using 
the expanded dataset (Supplementary Figure 4.1). Comparisons could not be made for number 
of treatments in the finisher because of lack of convergence. For number of treatments across the 
challenge nursery and finisher, estimates tended to be smaller for the expanded data set and 
differences were substantial for a number of MSA phenotype, in particular for PHA phenotypes.  
Mortality: For mortality in the challenge nursery, estimates of genetic correlations with 
MSA phenotypes generally followed expected trends, with negative estimates for individual time 
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points and AUC. The delta’s estimates for PMA followed the same trend observed of number of 
treatments in the challenge nursery, i.e. increasing from negative estimates for delta 72-48 to 
positive estimates for delta 96-48. Opposite trends were, however, observed for estimates for 
ConA and PHA, i.e. decreasing from positive for delta 72-48 to negative for delta 96-48. 
Differences between estimates based on BIS and stimulated mean were substantial for ConA at 
the individual time points, but were small for the ConA and for most MSA phenotypes to PHA 
and PMA.    
 For mortality in the finisher, estimates of genetic correlations with MSA phenotypes at 
individual time points were similar to those observed for mortality in the nursery, but estimates 
with AUC were much weaker for mortality in the finisher than in the nursery. There were no 
clear trends for correlations with the delta phenotypes, except that estimates with delta 96-72 
were large positive but with very large standard errors. Differences in estimates based on BIS 
and stimulated means were small for most MSA phenotypes, except for PHA and PMA at 48 hrs,  
 Patterns in estimates of genetic correlations of mortality across the nursery and finisher 
with MSA phenotypes at individual time points were very similar to those for mortality in the 
nursery and in the finisher but with a few more positive estimates. Estimates for delta phenotypes 
tended to be similar to those for mortality in the finisher, rather than to estimates for mortality in 
the nursery.  
 Health scores: Estimates of genetic correlations between MSA phenotypes with health 
scores are in Figure 4.1, with corresponding phenotypic correlations in Supplementary Table 
4.7. For the two health scores collected in the quarantine nursery, all pigs scored either as 4 or 5 
(Cheng et al., 2020) and there were no expected trends in the correlation estimates because of the 
high health status of at this stage. While there were no clear trends in estimates for the first 
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health score, the second health score tended towards positive genetic correlation estimates for 
individual time points and in particular for AUC. Additionally, for the delta phenotypes, all 
estimates were positive for PHA and negative for PMA. Genetic correlation estimates for the 
second health score had large standard errors because the heritability estimate for this health 
score was very low (0.00). Differences between estimates based on BIS and stimulated mean 
were small for both health scores, although there were a few instances where the estimates 
changed sign.  
 Estimates of genetic correlations for health scores in the challenge nursery and finisher 
were nearly all positive for all MSA phenotypes and across all three mitogens. Some estimates 
were strong but all had large standard errors. Generally, differences between estimates based on 
BIS and stimulated mean were small, but with some exceptions.  
 
Discussion 
Commercial pigs often face a wide variety of infectious swine diseases that are generally 
not observed in the nucleus herds. Selection for disease resilience is difficult due to the structure 
of the US swine production system and the lack of a DNA marker for marker-assisted selection. 
Identification of a genetic indicator trait for increased disease resilience that can be measured on 
young healthy pigs can be a pragmatic strategy that would facilitate the production of resilient 
commercial pigs while optimizing the efficiency of the swine industry, without requiring swine 
breeders to infect nucleus animals with disease or collect disease data in commercial herds.  
In this study, we measured the proliferation of PMCs from young healthy pigs after 
mitogen stimulation as possible genetic indicators for disease resilience. Through the use of an 
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MSA, we identified three mitogens (ConA, PHA, and PMA) whose in vitro PBMC stimulation 
phenotypes had moderate estimates of heritabilities. ConA, PHA, and PMA are commonly used 
as mitogens in in-vitro experiments to stimulate specific pathways and assess the immune 
response of an organism (Lin, 2012, Lamers et al., 1999, Paul, et al., 1979, Stepanova et al., 
2012, Tough, et al., 1997). Heritability is an important genetic parameter that determines to what 
extent an animal’s response is affected by genetics and, therefore, large heritabilities will lead to 
a substantial response of a trait to selection (Lush, 1937).   
Our estimates of heritability for ConA at 48 hrs (0.24 +0.08) are consistent with the 
findings from that of Edfors-Lilja et al. (2011) (0.38 +0.21) and Flori et al. (2011) (0.36 +0.20). 
However, there were numerical differences between our heritability estimates for PMA and LPS 
at time 48 (0.12 +0.08 and 0.00 +0.00) and those estimated by Flori et al. (2011) (0.27 +0.20 and 
0.31 +0.19). These differences can be attributed to many factors. First, Flori et al. (2011) 
response to mitogens three weeks after vaccination for Mycoplasma hyopneumoniae. Second, 
sample size in the study of Flori et al. (2011) was roughly half of ours, which resulted in standard 
errors for estimates of heritability to be roughly twice the size of ours. Third, different breeds 
were used in the two studies, Large White by Flori et al. (2011) versus Landrace x Yorkshire 
crossbreds in our study.   
For the three mitogens that resulted in sizeable estimates of heritabilities (ConA, PHA, 
and PMA), estimates of genetic correlations of MSA phenotypes with disease resilience followed 
expected trends in most cases. The overall trend for the estimates of genetic correlations between 
growth rate and health scores, with MSA traits was expected to be positive. This is because a 
faster response to mitogen induced immune cell proliferation is indicative of higher disease 
resilience. Therefore, animals with a greater response to mitogen stimulation, are expected to 
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gain weight faster than sick pigs and have higher health scores. For traits that were taken prior to 
the disease challenge, such as growth rate and health scores, there were no expected trends or 
patterns since these health scores were assigned prior to the disease challenge. Estimates of 
genetic correlations of treatment and mortality with MSA traits were expected to be negative. 
Animals with a greater response to mitogen stimulations are expected to require fewer treatments 
and result in fewer mortalities. Although one would expect number of treatments and health 
scores to be highly correlated, health scores are more objective because the choice whether or not 
to treat is removed. For instance, some sick pigs may have lower health scores but they are not 
sick enough to treat. 
Although none of the individual genetic correlation estimates were significantly different 
from zero, similar trends across mitogens and disease resilience traits suggest that at least the 
direction of the genetic correlations with disease resilience traits is as expected. This suggests 
that selection for higher MSA response to these three mitogens is expected to result in greater 
growth rate, higher health scores, fewer health treatments, and lower rates of mortality under a 
polymicrobial challenge. Biologically, higher rates of peripheral blood mononuclear cell 
proliferation in the blood of resilient pigs may coordinate a more efficient and responsive 
adaptive immune response, effectively expediting the expression of peripheral blood 
mononuclear cells and thus, mitigating the antagonistic physiological consequences of 
pathogenic infection.   
In order to determine which of the five mitogens would be the best to use for an MSA as 
a genetic indicator trait for disease resilience, we first considered estimates of heritability for the 
MSA. Since LPS and PWM MSA phenotypes had low estimates of heritability, we removed 
these two mitogens from consideration. In terms of heritability, there are no notable advantages 
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of using any of the remaining three mitogens over one another, although heritability estimates for 
ConA were moderate across all three time points, while PHA and PMA had lower estimates at 
48 and 96 hrs, especially PMA. AUC and delta phenotypes did not provide higher estimates of 
heritabilities for these three mitogens. After observing trends in heritability, visualizing estimates 
of genetic correlations of the MSA with disease resilience in Figure 4.1 and in Supplementary 
Figure 4.2 provided more insight into the suitability of the different MSA phenotypes as 
indicator traits for disease resilience. Based on these figures, MSA phenotypes based on ConA 
generally showed more consistent estimates in the expected direction across time points. 
Although PMA resulted in the numerically highest genetic correlation estimates, estimated for 
PMA and PHA were not as consistent relative to expectations and showed large standard errors. 
When comparing the MSA phenotypes of ConA between BIS and stimulated mean, there were 
few substantial differences and genetic correlation trends were generally the same between the 
two. Therefore, choosing either BIS or stimulated mean may yield no noticeable difference. 
Differences between expanded and survivor datasets were also small. However, Cheng et al. 
(2020) recommend using the expanded dataset because it reduces selection biases and includes 
more pigs into the analysis (Cheng et al., 2020). Based on these results, ConA showed the most 
promise as a genetic indicator for disease resilience. However, further studies are required to not 
only validate ConA’s potential as an indicator, but also to determine which mitogen time point 
may be the best. 
Conclusions 
Swine producers can benefit from using MSA of PBMCs isolated from the blood of 
young healthy pigs as genetic indicators of disease resilience. Estimates of heritability of 
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response to Concanavalin A were moderately high at each of the three time points after 
stimulation and across the three time points based on area under the curve. In most cases, the 
heritability estimates of phenotypes extracted from stimulation with phytohemagglutinin and 
phorbol myristate acetate were also moderately heritable, while those obtained from stimulation 
with pokeweed mitogen and lipopolysaccharide were lowly heritable. However, estimates of 
genetic correlations of response to Concanavalin A with disease resilience traits were more 
consistent across time and traits and followed expectations better than those of response to the 
other two heritable mitogens. between each mitogen with several disease resilience traits were 
also estimated, where correlations using ConA consistently followed expected trends with 
generally smaller standard errors than PHA and PMA. Thus, although these results should be 
validated to overcome large standard errors of estimates, swine breeders can benefit from 
utilizing in vitro MSA to ConA, using blood samples collected from young healthy pigs to select 
for increased disease resilience. 
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Table 4.1: Mean and within-sample coefficients of variation (CV) across six replicates for the 
number of live cells in unstimulated (restcount) and stimulated samples (Stim Mean). 
            Rest Count   Stim Mean 
Mitogen   Time   
Number of  
Samples 
  Mean CV (%)  Mean CV (%) 
 
Concanavalin A 
  48   860   4971.9 15.0   6700.0 21.5 
  72   873   5590.9 12.9   8313.7 21.3 
  96   871   5719.7 13.1   6679.8 16.3 
                      
Phytohemagglutinin  
  48   860   5814.7 13.1   6548.6 14.0 
  72   872   5029.5 13.3   7289.5 22.6 
  96   855   4224.8 14.0   7640.8 24.6 
                      
Poke Weed  
Mitogen 
  48   866   4003.3 15.4   8482.5 28.7 
  72   858   3970.6 15.0   5091.5 19.6 
  96   855   4052.4 15.7   4578.6 15.6 
                      
Lipopolysaccharide 
  48   859   3999.7 15.2   7116.5 25.0 
  72   862   3811.4 15.9   6768.2 24.8 
  96   856   4043.4 15.3   7608.4 26.0 
                      
Phorbol  
Myristate Acetate  
  48   854   4063.1 16.1   4737.9 18.6 
  72   868   4039.1 16.0   4412.2 15.5 
  96   869   4201.6 16.8   6856.8 24.9 
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Table 4.2: Basic statistics (mean and SD) and estimates of heritability (h2) and litter effects (c2) 
(SE in parentheses) for log(2) transformed BIS and stimulated mean phenotypes for each of 5 
mitogens at 3 time points (48, 72, and 96 hrs after stimulation), and for area under the curve 
(AUC) and for changes in phenotypes between time points (72-48, 96-48, and 96-72), as well as 
estimates of phenotypic (rp) and genetic (rg) correlations between corresponding BIS and 
stimulated mean phenotypes.  
 
 
48: 48 hrs; 72: 72 hrs; 96: 96 hrs; AUC: Area Under the Curve; 72 – 48: difference between 72 
hrs and 48 hrs; 96 – 72: difference between 96 hrs and 72 hrs; 96 – 48: difference between 96 
and 48 hrs; NE: not estimable 
Mitogen Time
Number 
of pigs
Mean SD h
2
 (SE) c
2
 (SE)
Number 
of pigs
Mean SD h
2
 (SE) c
2
 (SE) rp rg
48 860 0.30 0.37 0.24 (0.08) 0.00 (0.00) 863 12.4 0.90 0.30 (0.09) 0.00 (0.00) 0.89 0.62
72 873 0.70 0.63 0.27 (0.09) 0.00 (0.00) 868 12.6 0.89 0.28 (0.10) 0.00 (0.00) 0.97 1.04
96 871 0.66 0.61 0.23 (0.10) 0.00 (0.00) 866 12.5 0.83 0.17 (0.10) 0.04 (0.05) 0.89 0.93
AUC 850 43.43 36.45 0.24 (0.09) 0.00 (0.00) 859 1743 52.53 0.25 (0.10) 0.01 (0.05) 1.04 1.10
72-48 860 0.39 0.56 0.34 (0.10) 0.00 (0.00) 861 -0.4 0.78 0.37 (0.10) 0.00 (0.00) 1.21 0.71
96-72 871 -0.03 0.53 0.13 (0.09) 0.00 (0.00) 865 0.0 0.75 0.13 (0.09) 0.00 (0.00) 1.04 0.82
96-48 859 0.35 0.56 0.21 (0.10) 0.01 (0.05) 860 0.4 0.93 0.19 (0.09) 0.00 (0.00) 0.89 0.81
48 860 0.48 0.43 0.19 (0.09) 0.02 (0.05) 862 12.7 1.02 0.07 (0.09) 0.02 (0.06) 0.84 1.86
72 872 0.85 0.73 0.28 (0.09) 0.00 (0.00) 866 12.7 0.97 0.33 (0.10) 0.00 (0.00) 0.89 1.07
96 855 0.71 0.76 0.22 (0.10) 0.04 (0.05) 849 12.5 0.95 0.22 (0.10) 0.04 (0.05) 0.90 0.95
AUC 836 54.85 44.89 0.34 (0.09) 0.00 (0.00) 857 1759 60.78 0.28 (0.10) 0.00 (0.00) 0.90 0.75
72-48 859 0.37 0.58 0.13  (0.08) 0.00 (0.00) 857 -0.4 0.90 0.13 (0.08) 0.00 (0.00) 0.81 1.24
96-72 854 -0.15 0.55 0.14 (0.07) 0.00 (0.00) 846 0.1 0.63 0.10 (0.07) 0.00 (0.00) 1.01 0.89
96-48 842 0.23 0.62 0.18 (0.09) 0.01 (0.06) 845 0.2 1.08 0.18 (0.9) 0.01 (0.06) 0.74 1.01
48 866 0.14 0.29 0.00 (0.00) 0.01 (0.05) 863 12.3 0.91 0.00 (0.09) 0.01 (0.06) 0.96 1.44
72 858 0.32 0.32 0.10 (0.08) 0.00 (0.00) 864 12.2 0.58 0.15 (0.09) 0.00 (0.00) 0.83 0.62
96 855 0.20 0.37 0.09 (0.08) 0.00 (0.00) 865 12.1 0.55 0.07 (0.08) 0.00 (0.00) 0.82 0.70
AUC 848 20.11 19.14 0.03 (0.06) 0.00 (0.00) 848 1684 37.33 0.09 (0.08) 0.00 (0.00) 0.74 2.10
72-48 856 0.18 0.37 0.12 (0.08) 0.00 (0.00) 856 -0.2 0.82 0.13 (0.08) 0.00 (0.00) 0.96 0.83
96-72 856 -0.12 0.42 NE NE 856 0.1 0.59 NE NE NE NE
96-48 848 0.06 0.38 0.03 (0.07) 0.00 (0.00) 855 0.1 1.02 0.02 (0.07) 0.00 (0.00) 0.65 0.21
48 859 0.13 0.23 0.00 (0.00) 0.00 (0.00) 863 12.3 0.88 0.00 (0.09) 0.00 (0.00) NE NE
72 862 0.17 0.27 0.05 (0.07) 0.00 (0.00) 868 12.1 0.52 0.10 (0.09) 0.00 (0.00) 1.18 0.18
96 856 0.13 0.29 0.07 (0.09) 0.03 (0.06) 864 12.0 0.52 0.00 (0.09) 0.04 (0.06) 1.34 2.02
AUC 834 11.11 16.52 0.03 (0.06) 0.00 (0.00) 854 1671 33.93 0.00 (0.09) 0.08 (0.05) 0.60 0.41
72-48 849 0.04 0.27 0.01 (0.08) 0.00 (0.00) 849 0.0 0.72 0.02 (0.08) 0.00 (0.00) 1.71 -0.43
96-72 846 -0.03 0.29 NE NE 846 0.0 0.55 0.01 (0.08) 0.00 (0.00) NE NE
96-48 844 0.01 0.29 0.00 (0.00) 0.04 (0.05) 844 0.0 0.99 0.00 (0.00) 0.04 (0.05) 1.28 4.17
48 854 0.39 0.42 0.12 (0.08) 0.00 (0.00) 864 12.5 0.89 0.10 (0.09) 0.00 (0.01) 1.04 0.86
72 868 0.66 0.62 0.29 (0.09) 0.01 (0.05) 867 12.5 0.96 0.22 (0.09) 0.01 (0.05) 1.19 1.29
96 869 0.55 0.70 0.04 (0.06) 0.00 (0.00) 867 12.4 0.89 0.03 (0.06) 0.00 (0.00) 0.97 1.48
AUC 851 43.51 37.35 0.27 (0.10) 0.04 (0.06) 861 1716 61.37 0.30 (0.10) 0.00 (0.00) 0.78 1.21
72-48 852 0.27 0.53 0.26 (0.09) 0.00 (0.00) 861 -0.3 0.76 0.25 (0.09) 0.00 (0.00) 1.13 1.51
96-72 865 -0.11 0.56 0.05 (0.06) 0.00 (0.00) 867 0.1 0.83 0.04 (0.06) 0.00 (0.00) 1.04 1.22
96-48 852 0.15 0.64 0.13 (0.09) 0.01 (0.05) 861 0.2 0.90 0.13 (0.09) 0.01 (0.05) 1.03 0.86
Lipopolysaccharide
Phorbol 
Myristate Acetate 
BIS Stimulated Mean Correlation
Concanavalin A
Phytohemagglutinin 
Poke Weed 
Mitogen
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 Table 4.3: Estimates of genetic correlations for BIS (below diagonal) and Stimulated Means 
(above diagonal) (SE in parentheses) between time points (48, 72, or 72 hrs after stimulation) 
and for area under the curve (AUC) for each of five mitogens. 
Concanavalin A   48 72 96 AUC 
48     0.42 (0.21) 0.53 (0.23) 0.87 (0.12) 
72   0.24 (0.25)   0.11 (0.66) NE 
96   0.51 (0.22) 0.78 (0.15)   0.82 (0.14) 
AUC   0.41 (0.22) NE 0.90 (0.10)   
            
Phytohemagglutinin   48 72 96 AUC 
48     NE 0.73 (0.24) NE 
72   0.86 (0.14)   0.91 (0.09) NE 
96   0.68 (0.17) 0.83 (0.11)   0.92 (0.12) 
AUC   0.36 (0.22) NE 0.83 (0.10)   
            
Poke Weed Mitogen   48 72 96 AUC 
48     0.53 (0.31) 0.45 (0.55) 0.56 (0.69) 
72   NE   0.41 (0.80) 0.13 (0.91) 
96   NE 0.67 (0.43)   NE 
AUC   NE NE NE   
            
Lipopolysaccharide   48 72 96 AUC 
48     0.27 (0.41) 0.29 (0.44) 0.93 (0.25) 
72   NE   0.44 (0.41) 0.09 (0.84) 
96   NE NE   0.89 (0.56) 
AUC   NE NE NE   
            
Phorbol Myristate Acetate   48 72 96 AUC 
48     0.78 (0.24) 0.24 (0.63) NE 
72   0.65 (0.21)   NE 0.36 (0.46) 
96   0.46 (0.66) NE   0.21 (0.45) 
AUC   0.76 (0.14) NE NE   
 
48: 48 hrs; 72: 72 hrs; 96: 96 hrs; AUC: Area Under the Curve 
NE: not estimable.
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Table 4.4: Estimates of genetic correlations for BIS (below diagonal) and Stimulated Mean 
(above diagonal) data (SE in parentheses) between mitogens at a given time point (48, 72, or 72 
hrs after stimulation) and for area under the curve (AUC). 
Trait   Con A 48 PHA 48 PWM 48 LPS 48 PMA 48 
Con A 48     0.96 (0.72) NE 0.00 (0.00) NE 
PHA 48   0.65 (0.19)   NE 0.00 (0.00) 0.25 (0.79) 
PWM 48   NE NE   0.00 (0.00) NE 
LPS 48   NE NE NE   NE 
PMA 48   NE 0.73 (0.32) NE NE   
              
Trait   Con A 72 PHA 72 PWM 72 LPS 72 PMA 72 
Con A 72     0.74 (0.13) 0.00 (0.00) 0.40 (0.29) 0.92 (0.19) 
PHA 72   0.55 (0.17)   0.00 (0.00) 0.77 (0.27) 0.89 (0.16) 
PWM 72   0.00 (0.00) 0.00 (0.00)   NE NE 
LPS 72   0.65 (0.70) NE NE   0.53 (0.34) 
PMA 72   0.71 (0.16) 0.91 (0.12) 0.47 (0.31) 0.67 (1.17)   
              
Trait   Con A 96 PHA 96 PWM 96 LPS 96 PMA 96 
Con A 96     0.64 (0.19) 0.87 (0.33) 0.65 (1.19) NE 
PHA 96   0.62 (0.16)   0.44 (0.83) NE NE 
PWM 96   0.28 (0.50) 0.88 (0.37)   0.45 (0.71) 0.57 (0.74) 
LPS 96   0.60 (0.47) 0.13 (0.43) NE   NE 
PMA 96   NE 0.34 (0.72) NE NE   
              
Trait   Con A AUC PHA AUC PWM AUC LPS AUC PWM AUC  
Con A AUC     0.74 (0.12) 0.96 (0.21) 0.15 (0.44) 0.87 (0.17) 
PHA AUC   0.60 (0.15)   0.98 (0.11) 0.74 (0.36) 0.78 (0.11) 
PWM AUC   0.99 (0.89) NE   0.92 (0.50) NE 
LPS AUC   0.66 (0.94) 0.04 (0.74) NE   0.92 (0.50) 
PMA AUC    0.76 (0.16) 0.86 (0.11) NE NE   
 
Con A: Concanavalin A; PHA: Phytohemagglutinin; PWM: Poke Weed Mitogen; LPS: 
Lipopolysaccharide; PMA: Phorbol Myristate Acetate; AUC: Area Under the Curve 
NE: not estimable.
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Figure 4.1: Estimates of genetic correlations (and SE bars) of MSA phenotypes with disease 
resilience traits for Concanavalin A (blue), Phytohemagglutinin (yellow), and Phorbol Myristate 
Acetate (green), using BIS (solid bars) and stimulated mean (striped bars) MSA phenotypes.  
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Figure 4.1: (continued) 
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Figure 4.1: (continued) 
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Figure 4.1: (continued) 
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Figure 4.1: (continued)
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Figure 4.1: (continued) 
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Figure 4.1: (continued) 
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Supplementary Table 4.1: Mitogen Concentrations used in the Mitogen Stimulation Assays. 
Mitogen Chemical solution [stock] Cie # [4X] [final] 
A Concanavalin A con A 2 mg/mL Sigma SLBR2953V 20 g/mL 5 g/mL 
B Phytohemagglutinin PHA-L 1 mg/mL Sigma SLBJ2065V 4 g/mL 1 g/mL 
C Pokeweed Mitogen PWM 1 mg/mL Sigma SLBB6519V 10 g/mL 
2.5 
g/mL 
D 
Lipopolysaccharide LPS 4 mg/mL 
Invivo 
Gen 
13106-MM 4 g/mL 1 g/mL 
Dextran Sulfate DxS 
400 
g/mL 
Sigma BCBN6770V 4 g/mL 1 g/mL 
E 
Phorbol 12-
Myristate 13-
Acetate 
PMA 
100 
g/mL 
Sigma D00145003 40 ng/mL 10 ng/mL 
Ionomycin Iono 1 mg/mL Sigma GBC18082012 1 g/mL 
250 
ng/mL 
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Supplementary Table 4.2: Estimates of phenotypic correlations for BIS (below diagonal) and 
Stimulated Means (above diagonal) (SE in parentheses) between time points (48, 72, or 72 hrs 
after stimulation) and for area under the curve (AUC) for each of five mitogens. 
Concanavalin A   48 72 96 AUC 
48     0.53 (0.03) 0.50 (0.04) 0.77 (0.02) 
72   0.44 (0.03)   0.02 (0.05) NE 
96   0.47 (0.03) 0.66 (0.02)   0.66 (0.02) 
AUC   0.61 (0.02) NE 0.68 (0.02)   
            
Phytohemagglutinin   48 72 96 AUC 
48     NE 0.48 (0.04) NE 
72   0.56 (0.02)   0.64 (0.03) NE 
96   0.53 (0.03) 0.63 (0.02)   0.63 (0.03) 
AUC   0.65 (0.02) NE 0.66 (0.02)   
            
Poke Weed Mitogen   48 72 96 AUC 
48     0.44 (0.04) 0.07 (0.05) 0.65 (0.03) 
72   NE   0.43 (0.04) 0.02 (0.06) 
96   NE 0.31 (0.04)   NE 
AUC   NE NE NE   
            
Lipopolysaccharide   48 72 96 AUC 
48     0.39 (0.04) 0.31 (0.04) 0.71 (0.03) 
72   NE   0.38 (0.04) 0.01 (0.06) 
96   NE NE   0.33 (0.04) 
AUC   NE NE 0.89 (0.56)   
            
Phorbol Myristate Acetate   48 72 96 AUC 
48     0.54 (0.03) 0.49 (0.04) NE 
72   0.52 (0.03)   NE 0.11 (0.08) 
96   0.39 (0.03) NE   0.48 (0.03) 
AUC   0.68 (0.02) NE NE   
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Supplementary Table 4.3: Estimates of phenotypic correlations for BIS (below diagonal) and 
Stimulated Mean (above diagonal) data (SE in parentheses) between mitogens at a given time 
point (48, 72, or 72 hrs after stimulation) and for area under the curve (AUC) 
Trait   Con A 48 PHA 48 PWM 48 LPS 48 PMA 48 
Con A 48     0.56 (0.03) NE 0.36 (0.04) NE 
PHA 48   0.51 (0.03)   NE 0.35 (0.04) 0.35 (0.04) 
PWM 48   NE NE   0.42 (0.04) 0.56 (0.00) 
LPS 48   NE NE NE   0.33 (0.04) 
PMA 48   NE 0.36 (0.03) NE NE   
              
Trait   Con A 72 PHA 72 PWM 72 LPS 72 PMA 72 
Con A 72     0.66 (0.03) 0.47 (0.03) 0.27 (0.04) 0.51 (0.03) 
PHA 72   0.61 (0.02)   0.51 (0.03) 0.27 (0.04) 0.51 (0.03) 
PWM 72   0.43 (0.03) 0.41 (0.03)   NE NE 
LPS 72   0.08 (0.04) NE NE   0.23 (0.04) 
PMA 72   0.51 (0.03) 0.56 (0.02) 0.40 (0.03) 0.10 (0.04)   
              
Trait   Con A 96 PHA 96 PWM 96 LPS 96 PMA 96 
Con A 96     0.64 (0.03) 0.50 (0.03) 0.21 (0.04) NE 
PHA 96   0.64 (0.02)   0.45 (0.04) NE NE 
PWM 96   0.44 (0.03) 0.43 (0.03)   0.24 (0.04) 0.51 (0.03) 
LPS 96   0.05 (0.04) 0.05 (0.04) NE   NE 
PMA 96   NE 0.41 (0.03) NE NE   
              
Trait   Con A AUC PHA AUC PWM AUC LPS AUC PMA AUC  
Con A AUC     0.72 (0.02) 0.58 (0.03) 0.30 (0.04) 0.61 (0.03) 
PHA AUC   0.63 (0.02)   0.65 (0.03) 0.36 (0.04) 0.62 (0.03) 
PWM AUC   0.46 (0.03) NE   0.35 (0.04) 0.95 (1.59) 
LPS AUC   0.10 (0.04) 0.00 (0.04) NE   0.26 (0.04) 
PWM AUC    0.54 (0.03) 0.58 (0.02) NE NE   
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Supplementary Table 4.4: Frequency of treatment and mortality reasons  
 
Treatment Reason    Count Mortality Reason    Count 
Respiratory distress (Thumping)   1369 Poor/skinny/hairy/Failure to thrive   289 
Grey/Brown Scours   956 Thumping/Heavy breathing   187 
Coughing   555 Sudden death   114 
Lameness   449 Slaughter house   100 
Yellow Scours (Salmonella)   383 Meningitis   61 
Arthritis (swollen joint)   372 Arrival   50 
Failure to Thrive/Poor/Skinny/Hairy   294 Lameness/arthritis   28 
Meningitis (Convulsions)   95 Sampling   25 
Conjunctivitis   94 Generalized weakness   12 
Red Scours (Dysentry)   86 Yellow Scours (Salmonella)   10 
Inappetance   83 Runt/ Cull   10 
Greasy pig disease   63 Grey/Brown Scours   9 
Erysipelas   32 Ataxia   7 
Ataxia   21 Hernia   6 
Fever   7 Scours   4 
Preripheral cyanosis   5 Fracture/sprain   4 
Rectal prolapse   3 Inappetance   4 
Tail/Ear/Flank biting   1 Rectal prolapse   4 
Other   34 Fighting   3 
     Greasy pig disease   2 
   Paralysed   2 
   Stressed   2 
   White (anemia)   2 
   Bleeding   1 
   Peripheral cyanosis   1 
   Tail/Ear/Flank biting   1 
   Intestinal torsion   1 
   Other   34 
 
 
 
 
 
 
104 
 
Supplementary Table 4.5: Estimates of phenotypic correlations (SE in parentheses) of MSA 
phenotypes with disease resilience traits for BIS.  
  
Survivor: data includes only pigs that reached slaughter; Expanded: data includes imputed and 
expanded phenotypes for pigs that died but that were included in the analyses with associate 
weight greater than 0.75; qNurADG: average daily gain in quarantine nursery; cNurADG: 
average daily gain in challenge nursery; FinADG: average daily gain in finisher; NurTRT: 
number of treatments per pig in challenge nursery; FinTRT: number of treatments per pig in 
finisher; ALLTRT: number of treatments per pig in challenge nursery and finisher; NurMOR: 
mortality rate for pigs in challenge nursery; FinMOR: mortality rate for pigs in finisher; 
ALLMOR: mortality rate for pigs in challenge nursery and finisher; Con A: Concanavalin A; 
PHA: Phytohemagglutinin; PWM: Poke Weed Mitogen; LPS: Lipopolysaccharide; PMA: 
Phorbol Myristate Acetate; AUC: Area Under the Curve; 48: 48 hrs; 72: 72 hrs; 96: 96 hrs; 72 – 
48: difference between 72 hrs and 48 hrs; 96 – 72: difference between 96 hrs and 72 hrs; 96 – 48: 
difference between 96 and 48 hrs. 
Trait qNurADG cNurADG 2 FinADG NurTRT FinTRT AllTRT NurMOR FinMOR AllMOR FinADG FinTRT AllMOR 
Con A 48 -0.11 (0.04) 0.07 (0.04) -0.03 (0.05) -0.03 (0.04) -0.04 (0.05) 0.00 (0.04) 0.00 (0.04) -0.01 (0.04) 0.00 (0.04) -0.02 (0.05) NE -0.27 (0.29)
Con A 72 -0.05 (0.04) 0.12 (0.04) 0.00 (0.05) -0.05 (0.04) -0.01 (0.05) -0.03 (0.04) 0.02 (0.04) 0.02 (0.04) -0.05 (0.04) -0.01 (0.05) NE -0.02 (0.04)
Con A 96 -0.03 (0.04) 0.05 (0.04) -0.01 (0.05) 0.01 (0.04) -0.08 (0.05) -0.01 (0.04) -0.05 (0.04) -0.04 (0.04) -0.02 (0.04) 0.01 (0.05) NE -0.02 (0.04)
Con A AUC -0.08 (0.04) 0.11 (0.04) -0.01 (0.05) -0.04 (0.04) -0.03 (0.05) -0.02 (0.04) 0.01 (0.04) 0.00 (0.04) -0.04 (0.04) 0.00 (0.01) NE 0.00 (0.07)
72-48 0.05 (0.04) -0.06 (0.04) 0.00 (0.05) 0.04 (0.04) NE 0.00 (0.04) -0.03 (0.04) 0.00 (0.04) 0.03 (0.04) 0.02 (0.05) NE -0.05 (0.04)
96-48 0.00 (0.04) 0.04 (0.04) 0.00 (0.05) -0.03 (0.04) NE 0.02 (0.04) 0.06 (0.04) -0.05 (0.04) -0.02 (0.04) 0.00 (0.04) NE 0.04 (0.04)
96-72 0.05 (0.04) 0.01 (0.04) 0.02 (0.05) -0.01 (0.04) NE -0.03 (0.04) -0.04 (0.04) 0.03 (0.04) -0.02 (0.04) 0.02 (0.05) NE 0.00 (0.04)
PHA 48 -0.09 (0.04) 0.07 (0.04) -0.06 (0.05) -0.04 (0.04) -0.07 (0.05) -0.01 (0.04) -0.07 (0.04) -0.07 (0.04) 0.04 (0.04) -0.06 (0.05) NE -0.02 (0.04)
PHA 72 -0.10 (0.04) 0.02 (0.04) -0.03 (0.05) 0.03 (0.04) 0.05 (0.05) 0.02 (0.04) -0.02 (0.04) -0.02 (0.04) 0.03 (0.04) -0.03 (0.05) NE 0.00 (0.04)
PHA 96 -0.08 (0.04) 0.14 (0.04) 0.02 (0.05) -0.04 (0.04) -0.05 (0.05) 0.00 (0.04) -0.01 (0.04) -0.01 (0.04) -0.04 (0.04) 0.02 (0.05) NE 0.00 (0.04)
PHA AUC -0.12 (0.04) 0.02 (0.04) -0.02 (0.05) 0.02 (0.04) 0.02 (0.05) 0.02 (0.04) -0.04 (0.04) -0.04 (0.04) 0.04 (0.04) 0.04 (0.04) NE 0.00 (0.04)
72-48 -0.03 (0.04) 0.02 (0.04) -0.03 (0.05) -0.02 (0.04) NE -0.04 (0.04) -0.03 (0.04) -0.07 (0.04) -0.03 (0.04) 0.02 (0.04) NE 0.00 (0.04)
96-48 0.01 (0.04) -0.13 (0.04) -0.04 (0.05) 0.07 (0.04) NE 0.05 (0.04) 0.00 (0.04) 0.06 (0.04) 0.03 (0.04) 0.04 (0.05) NE 0.00 (0.04)
96-72 -0.03 (0.04) 0.09 (0.04) 0.06 (0.05) -0.05 (0.04) NE -0.02 (0.04) 0.03 (0.04) 0.00 (0.04) 0.00 (0.04) 0.12 (0.05) NE 0.00 (0.04)
PMA 48 -0.10 (0.04) 0.04 (0.04) -0.03 (0.05) -0.06 (0.04) NE 0.01 (0.04) 0.02 (0.04) -0.01 (0.04) 0.01 (0.04) NE NE -0.07 (0.04)
PMA 72 -0.07 (0.04) 0.06 (0.04) 0.03 (0.05) -0.04 (0.04) NE -0.02 (0.04) -0.02 (0.04) -0.01 (0.04) -0.02 (0.04) 0.09 (0.05) NE -0.10 (0.04)
PMA 96 -0.06 (0.04) 0.02 (0.04) -0.02 (0.04) -0.04 (0.04) NE -0.03 (0.04) -0.03 (0.04) 0.05 (0.04) -0.02 (0.04) 0.07 (0.05) NE -0.13 (0.04)
PWM AUC -0.08 (0.04) 0.06 (0.04) 0.01 (0.05) -0.04 (0.04) NE -0.02 (0.04) -0.01 (0.04) -0.01 (0.04) -0.01 (0.04) 0.03 (0.05) NE -0.01 (0.02)
72-48 0.02 (0.04) -0.04 (0.04) -0.04 (0.05) 0.00 (0.04) NE 0.03 (0.04) 0.06 (0.04) 0.01 (0.04) 0.08 (0.04) 0.02 (0.05) NE -0.03 (0.04)
96-48 0.00 (0.04) 0.03 (0.04) 0.01 (0.05) 0.00 (0.04) NE 0.04 (0.04) -0.08 (0.04) 0.02 (0.04) -0.04 (0.04) NE NE NE
96-72 0.03 (0.04) 0.01 (0.04) 0.03 (0.05) 0.07 (0.04) NE -0.01 (0.04) -0.02 (0.04) -0.08 (0.04) -0.09 (0.04) NE NE NE
PWM 48 0.00 (0.01) 0.04 (0.04) -0.06 (0.05) -0.04 (0.04) -0.03 (0.05) -0.06 (0.04) 0.03 (0.04) 0.05 (0.04) 0.06 (0.04) NE NE NE
PWM 72 0.06 (0.04) 0.03 (0.04) 0.07 (0.05) -0.06 (0.04) 0.03 (0.05) -0.09 (0.04) -0.02 (0.04) -0.02 (0.04) -0.02 (0.04) -0.01 (0.05) NE -0.01 (0.04)
PWM 96 -0.03 (0.04) 0.04 (0.04) 0.05 (0.05) -0.07 (0.04) -0.06 (0.05) -0.09 (0.04) -0.03 (0.04) -0.02 (0.04) 0.00 (0.04) 0.02 (0.05) NE 0.02 (0.04)
PWM AUC 0.01 (0.04) 0.03 (0.04) 0.06 (0.05) -0.06 (0.04) 0.01 (0.05) -0.10 (0.04) -0.03 (0.04) -0.03 (0.04) 0.01 (0.04) 0.04 (0.02) NE -0.01 (0.03)
72-48 0.13 (0.04) -0.02 (0.04) -0.12 (0.05) 0.06 (0.04) NE 0.05 (0.04) 0.01 (0.04) 0.01 (0.04) 0.06 (0.04) NE NE NE
96-48 -0.27 (0.00) NE NE NE NE NE NE NE NE NE NE NE
96-72 0.04 (0.04) NE NE NE NE NE NE NE NE NE NE NE
LPS 48 -0.07 (0.04) NE NE NE NE NE NE NE NE -0.03 (0.05) NE -0.04 (0.04)
LPS 72 -0.09 (0.04) 0.03 (0.04) 0.02 (0.05) 0.00 (0.04) 0.10 (0.05) -0.04 (0.04) 0.00 (0.04) 0.00 (0.04) 0.00 (0.04) 0.05 (0.02) NE 0.04 (0.10)
LPS 96 -0.04 (0.04) 0.00 (0.04) 0.03 (0.05) -0.01 (0.04) -0.06 (0.05) 0.01 (0.04) -0.02 (0.04) 0.00 (0.04) -0.02 (0.04) 0.02 (0.05) NE -0.10 (0.04)
LPS AUC -0.10 (0.04) 0.04 (0.04) 0.00 (0.05) -0.02 (0.04) -0.02 (0.04) -0.02 (0.04) 0.02 (0.05) 0.02 (0.04) 0.02 (0.04) 0.00 (0.05) NE -0.12 (0.04)
72-48 NE NE NE NE NE NE NE NE 0.12 (0.04) NE -0.06 (0.04)
96-48 0.05 (0.04) NE NE NE NE NE NE NE NE N/W NE -0.04 (0.04)
96-72 0.03 (0.04) NE NE NE NE NE NE NE NE 0.04 (0.04) NE -0.10 (0.04)
ExpandedSurvivor
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Supplementary Table 4.6: Estimates of phenotypic correlations (SE in parentheses) of MSA 
phenotypes with disease resilience traits for Stimulated Mean.  
 
qNurADG: average daily gain in quarantine nursery; cNurADG: average daily gain in challenge 
nursery; FinADG: average daily gain in finisher; NurTRT: number of treatments per pig in 
challenge nursery; FinTRT: number of treatments per pig in finisher; ALLTRT: number of 
treatments per pig in challenge nursery and finisher; NurMOR: mortality rate for pigs in 
challenge nursery; FinMOR: mortality rate for pigs in finisher; ALLMOR: mortality rate for pigs 
in challenge nursery and finisher; Con A: Concanavalin A; PHA: Phytohemagglutinin; PWM: 
Poke Weed Mitogen; LPS: Lipopolysaccharide; PMA: Phorbol Myristate Acetate. AUC: Area 
Under the Curve; 48: 48 hrs; 72: 72 hrs; 96: 96 hrs; 72 – 48: difference between 72 hrs and 48 
hrs; 96 – 72: difference between 96 hrs and 72 hrs; 96 – 48: difference between 96 and 48 hrs. 
Trait qNurADG cNurADG FinADG NurTRT FinTRT AllTRT NurMOR FinMOR AllMOR 
Con A 48 -0.12 (0.04) 0.07 (0.03) -0.01 (0.03) -0.11 (0.10) NE -0.04 (0.12) -0.03 (0.06) -0.04 (0.08) -0.02 (0.08)
Con A 72 -0.05 (0.04) 0.10 (0.03) 0.00 (0.03) -0.10 (0.10) NE -0.11 (0.11) -0.09 (0.06) -0.06 (0.07) 0.02 (0.07)
Con A 96 -0.02 (0.04) 0.05 (0.03) 0.01 (0.03) 0.02 (0.10) NE -0.05 (0.11) -0.02 (0.05) -0.08 (0.07) -0.09 (0.08)
Con A AUC -0.08 (0.04) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00)
72-48 0.04 (0.04) -0.09 (0.04) -0.01 (0.05) 0.05 (0.04) NE 0.00 (0.04) -0.05 (0.04) 0.00 (0.04) 0.03 (0.04)
96-48 0.00 (0.04) 0.04 (0.04) 0.00 (0.05) -0.03 (0.04) NE 0.03 (0.04) 0.07 (0.04) -0.04 (0.04) -0.02 (0.04)
96-72 0.06 (0.04) 0.02 (0.04) 0.02 (0.05) -0.01 (0.04) NE -0.04 (0.04) -0.04 (0.04) 0.04 (0.04) -0.01 (0.04)
PHA 48 -0.08 (0.04) 0.06 (0.04) -0.07 (0.04) -0.08 (0.10) -0.18 (0.12) -0.06 (0.12) 0.10 (0.07) -0.04 (0.08) -0.17 (0.10)
PHA 72 -0.09 (0.04) 0.03 (0.02) -0.01 (0.02) -0.01 (0.10) -0.04 (0.14) -0.07 (0.11) 0.01 (0.05) -0.05 (0.06) -0.07 (0.06)
PHA 96 -0.06 (0.04) 0.08 (0.02) 0.01 (0.02) -0.12 (0.09) -0.20 (0.15) -0.07 (0.11) -0.05 (0.04) -0.08 (0.05) -0.03 (0.05)
PHA AUC -0.09 (0.04) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00)
72-48 -0.01 (0.04) 0.02 (0.04) -0.04 (0.05) -0.01 (0.04) NE -0.03 (0.04) -0.03 (0.04) -0.07 (0.04) -0.03 (0.04)
96-48 0.02 (0.04) -0.12 (0.04) -0.05 (0.05) 0.07 (0.04) NE 0.05 (0.04) 0.00 (0.04) 0.05 (0.04) 0.02 (0.04)
96-72 0.00 (0.04) 0.09 (0.04) 0.07 (0.05) -0.06 (0.04) NE -0.02 (0.04) 0.03 (0.04) 0.00 (0.04) 0.00 (0.04)
PMA 48 -0.10 (0.04) 0.04 (0.04) -0.02 (0.04) -0.29 (0.11) 0.15 (0.12) -0.21 (0.12) -0.04 (0.07) 0.01 (0.08) 0.07 (0.09)
PMA 72 -0.06 (0.04) 0.06 (0.03) 0.05 (0.03) -0.13 (0.10) -0.04 (0.12) -0.25 (0.12) -0.04 (0.06) -0.09 (0.08) -0.08 (0.08)
PMA 96 -0.08 (0.04) 0.05 (0.05) 0.00 (0.04) -0.18 (0.11) -0.30 (0.15) -0.34 (0.12) 0.07 (0.08) -0.04 (0.08) -0.14 (0.10)
PWM AUC -0.11 (0.04) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.00 (0.07) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00)
72-48 0.02 (0.04) -0.05 (0.04) -0.04 (0.05) 0.01 (0.04) NE 0.03 (0.04) 0.05 (0.04) 0.00 (0.04) 0.08 (0.04)
96-48 -0.05 (0.04) 0.04 (0.04) 0.00 (0.05) -0.07 (0.04) NE -0.03 (0.04) 0.02 (0.04) 0.00 (0.04) 0.04 (0.04)
96-72 0.00 (0.04) 0.02 (0.04 0.04 (0.05 0.05 (0.04 NE -0.02 (0.04 -0.08 (0.04 -0.01 (0.04 0.00 (0.32
PWM 48 -0.01 (0.01) 0.00 (0.02) 0.02 (0.03) -0.22 (0.10) NE -0.21 (0.12) 0.03 (0.05) 0.05 (0.06) 0.03 (0.06)
PWM 72 0.05 (0.04) 0.05 (0.03) 0.03 (0.03) -0.20 (0.10) NE -0.22 (0.12) -0.07 (0.06) -0.07 (0.07) -0.01 (0.08)
PWM 96 -0.06 (0.04) 0.03 (0.03) 0.02 (0.03) -0.10 (0.10) NE -0.17 (0.12) -0.04 (0.05) -0.05 (0.07) -0.02 (0.07)
PWM AUC -0.01 (0.04) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) NE 0.00 (0.05) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00)
72-48 0.14 (0.04) -0.02 (0.04) -0.12 (0.05) 0.06 (0.04) NE 0.05 (0.04) 0.01 (0.04) 0.01 (0.04) 0.06 (0.04)
96-48 -0.06 (0.03) NE NE NE NE NE NE NE NE
96-72 0.03 (0.04) NE NE NE NE NE NE NE NE
LPS 48 -0.07 (0.04) 0.02 (0.03) 0.02 (0.03) -0.12 (0.11) NE -0.23 (0.12) 0.02 (0.06) 0.04 (0.07) -0.08 (0.08)
LPS 72 -0.08 (0.04) 0.01 (0.03) 0.02 (0.04) -0.03 (0.11) NE -0.10 (0.12) 0.04 (0.07) 0.08 (0.08) 0.07 (0.08)
LPS 96 -0.03 (0.04) 0.00 (0.04) 0.01 (0.04) 0.03 (0.05) NE 0.08 (0.09) -0.05 (0.08) -0.09 (0.09) -0.07 (0.10)
LPS AUC -0.08 (0.04) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) NE 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00)
72-48 0.02 (0.04) NE NE NE NE NE NE NE NE
96-48 0.07 (0.16) NE NE NE NE NE NE NE NE
96-72 0.02 (0.04) NE NE NE NE NE NE NE NE
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Supplementary Table 4.7: Estimates of phenotypic correlations (SE in parentheses) of MSA 
phenotypes with health score traits for both BIS and Stimulated Mean.  
 
qHScore1: health score on the day of entry into the quarantine nursery; qHScore2: health score 
on two weeks after entry into the quarantine nursery; cHScore: health score on two weeks after 
entry into challenge nursery; FinHScore: health score on 6 weeks after entry into the finisher; 
Con A: Concanavalin A; PHA: Phytohemagglutinin; PWM: Poke Weed Mitogen; LPS: 
Lipopolysaccharide; PMA: Phorbol Myristate Acetate; AUC: Area Under the Curve; 48: 48 hrs; 
72: 72 hrs; 96: 96 hrs; 72 – 48: difference between 72 hrs and 48 hrs; 96 – 72: difference 
between 96 hrs and 72 hrs; 96 – 48: difference between 96 and 48 hrs.
Trait qHScore 1 qHScore 2 cHScore FinHScore qHScore 1 qHScore 2 cHScore FinHScore
Con A 48 0.10 (0.04) -0.01 (0.04) 0.00 (0.04) -0.04 (0.04) 0.08 (0.04) 0.01 (0.04) 0.02 (0.04) -0.01 (0.04)
Con A 72 0.06 (0.04) -0.05 (0.04) -0.07 (0.04) -0.05 (0.04) 0.06 (0.04) -0.05 (0.04) -0.05 (0.04) -0.05 (0.04)
Con A 96 -0.01 (0.04) 0.01 (0.04) -0.01 (0.04) -0.03 (0.04) -0.03 (0.04) 0.01 (0.04) 0.00 (0.04) -0.03 (0.04)
Con A AUC 0.08 (0.04) -0.05 (0.04) -0.07 (0.04) -0.06 (0.04) 0.05 (0.04) -0.06 (0.04) -0.03 (0.04) -0.05 (0.04)
72-48 0.00 (0.04) -0.07 (0.04) -0.09 (0.04) -0.04 (0.04) -0.03 (0.04) -0.09 (0.04) -0.09 (0.04) -0.05 (0.04)
96-72 -0.08 (0.04) 0.07 (0.04) 0.07 (0.04) 0.02 (0.04) -0.08 (0.04) 0.07 (0.04) 0.08 (0.04) 0.03 (0.04)
96-48 -0.07 (0.04) 0.00 (0.04) -0.03 (0.04) -0.02 (0.04) -0.10 (0.04) 0.00 (0.04) -0.01 (0.04) 0.00 (0.04)
PHA 48 0.07 (0.04) 0.03 (0.04) 0.07 (0.04) 0.06 (0.04) 0.07 (0.04) 0.02 (0.04) 0.05 (0.04) 0.08 (0.04)
PHA 72 0.00 (0.04) 0.02 (0.04) 0.00 (0.04) 0.02 (0.04) 0.00 (0.04) 0.02 (0.04) 0.02 (0.04) 0.03 (0.04)
PHA 96 0.08 (0.04) -0.04 (0.04) -0.01 (0.04) 0.02 (0.04) 0.08 (0.04) -0.04 (0.04) 0.00 (0.04) 0.02 (0.04)
PHA AUC 0.01 (0.05) 0.03 (0.04) 0.02 (0.04) 0.05 (0.04) 0.00 (0.04) 0.02 (0.04) 0.04 (0.04) 0.03 (0.04)
72-48 -0.05 (0.04) 0.00 (0.04) -0.06 (0.04) -0.03 (0.04) -0.07 (0.04) -0.02 (0.04) -0.03 (0.04) -0.02 (0.04)
96-72 0.09 (0.04) -0.06 (0.04) 0.00 (0.04) -0.01 (0.04) 0.08 (0.04) -0.05 (0.04) -0.01 (0.04) -0.02 (0.04)
96-48 0.04 (0.04) -0.05 (0.04) -0.04 (0.04) -0.02 (0.04) 0.02 (0.05) -0.04 (0.04) -0.01 (0.04) -0.01 (0.05)
PMA 48 0.03 (0.04) -0.06 (0.04) -0.03 (0.04) -0.03 (0.04) 0.03 (0.04) -0.06 (0.04) -0.03 (0.04) -0.03 (0.04)
PMA 72 0.01 (0.04) -0.07 (0.04) -0.08 (0.04) -0.06 (0.04) 0.00 (0.04) -0.05 (0.04) -0.05 (0.04) -0.04 (0.04)
PMA 96 0.07 (0.04) 0.03 (0.04) -0.04 (0.04) -0.01 (0.04) 0.08 (0.04) 0.01 (0.04) -0.05 (0.04) -0.03 (0.04)
PWM AUC 0.02 (0.05) -0.07 (0.04) -0.07 (0.04) -0.06 (0.04) 0.01 (0.04) -0.05 (0.04) -0.04 (0.04) -0.04 (0.04)
72-48 -0.02 (0.04) -0.01 (0.04) -0.03 (0.04) -0.03 (0.04) -0.01 (0.04) 0.04 (0.04) 0.00 (0.04) 0.00 (0.04)
96-72 0.09 (0.05) 0.07 (0.04) -0.01 (0.04) 0.03 (0.04) 0.08 (0.04) 0.03 (0.04) 0.02 (0.04) 0.01 (0.04)
96-48 0.03 (0.05) 0.07 (0.04) -0.02 (0.04) 0.01 (0.05) 0.04 (0.04) 0.05 (0.04) 0.00 (0.04) 0.01 (0.04)
PWM 48 0.11 (0.04) 0.03 (0.04) 0.02 (0.04) -0.01 (0.04) 0.00 (0.08) -0.02 (0.04) 0.02 (0.04) -0.02 (0.04)
PWM 72 0.06 (0.04) -0.01 (0.04) -0.04 (0.04) -0.04 (0.04) 0.07 (0.04) -0.01 (0.04) -0.05 (0.04) -0.04 (0.04)
PWM 96 0.03 (0.04) 0.00 (0.04) -0.05 (0.04) -0.05 (0.04) 0.03 (0.04) 0.01 (0.04) -0.02 (0.04) -0.02 (0.04)
PWM AUC 0.06 (0.05) -0.07 (0.04) -0.03 (0.04) -0.05 (0.04) 0.08 (0.04) -0.05 (0.04) -0.03 (0.04) -0.04 (0.04)
72-48 0.02 (0.02) 0.01 (0.04) 0.00 (0.04) 0.00 (0.04) -0.03 (0.04) 0.00 (0.04) -0.04 (0.04) -0.02 (0.04)
96-72 -0.03 (0.04) -0.01 (0.04) -0.01 (0.04) -0.01 (0.04) -0.02 (0.04) 0.03 (0.04) 0.04 (0.04) -0.01 (0.04)
96-48 -0.46 (0.04) 0.01 (0.04) -0.06 (0.04) 0.03 (0.06) -0.45 (0.02) 0.00 (0.05) -0.05 (0.05) -0.06 (0.05)
LPS 48 0.09 (0.04) 0.00 (0.04) 0.00 (0.04) -0.05 (0.04) 0.09 (0.04) 0.00 (0.04) 0.00 (0.04) -0.05 (0.04)
LPS 72 0.02 (0.04) -0.05 (0.04) 0.01 (0.04) 0.00 (0.04) 0.01 (0.04) -0.06 (0.04) 0.02 (0.04) -0.01 (0.04)
LPS 96 -0.02 (0.04) 0.04 (0.04) 0.02 (0.04) 0.04 (0.04) -0.03 (0.04) 0.03 (0.04) 0.03 (0.04) 0.04 (0.04)
LPS AUC 0.06 (0.05) -0.05 (0.04) 0.00 (0.04) -0.01 (0.04) 0.03 (0.04) -0.05 (0.04) 0.00 (0.04) -0.02 (0.04)
72-48 -0.05 (0.04) -0.06 (0.04) 0.01 (0.04) 0.02 (0.04) -0.09 (0.04) -0.06 (0.04) 0.03 (0.04) 0.02 (0.05)
96-72 -0.04 (0.04) 0.09 (0.04) 0.02 (0.04) 0.05 (0.04) -0.01 (0.04) 0.08 (0.04) -0.01 (0.04) 0.02 (0.04)
96-48 -0.08 (0.04) 0.04 (0.04) 0.03 (0.04) 0.07 (0.04) -0.09 (0.04) 0.05 (0.04) 0.05 (0.04) 0.08 (0.04)
BIS Stimulated Mean
107 
 
 
 
Supplementary Figure 4.1: Estimates of genetic correlations (and SE bars) of MSA phenotypes 
with disease resilience traits for Concanavalin A (Con A) in blue, Phytohemagglutinin (PMA) in 
yellow, and Phorbol Myristate Acetate (PMA) in green, using the Survivor (solid) and Expanded 
(striped) data sets. 
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Supplementary Figure 4.1 (continued) 
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Supplementary Figure 4.2: Heat map displaying estimates of genetic correlations (and SE) of 
MSA phenotypes with disease resilience traits for Concanavalin A (ConA), Phytohemagglutinin 
(PHA), and Phorbol Myristate Acetate (PMA).  
 
cNurADG: average daily gain in challenge nursery; FinADG: average daily gain in finisher; 
NurTRT: number of treatments per pig in challenge nursery; FinTRT: number of treatments per 
pig in finisher; ALLTRT: number of treatments per pig in challenge nursery and finisher; 
NurMOR: mortality rate for pigs in challenge nursery; FinMOR: mortality rate for pigs in 
finisher; ALLMOR: mortality rate for pigs in challenge nursery and finisher; ConA: 
Concanavalin A; PHA: Phytohemagglutinin; PMA: Phorbol Myristate Acetate. AUC: Area 
Under the Curve; 48: 48 hrs; 72: 72 hrs; 96: 96 hrs; 72 – 48: difference between 72 hrs and 48 
hrs; 96 – 72: difference between 96 hrs and 72 hrs; 96 – 48: difference between 96 and 48 hrs.  
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CHAPTER 5. DISCUSSION AND CONCLUSION 
The objective of this thesis was to investigate the possibility of using SNP WUR10000125 
(WUR) and Mitogen Stimulation Assays (MSAs) as possible genetic indicators to select for 
disease resilience in high-health nucleus breeding populations. Production losses due to 
infectious swine pathogens have a direct economic impact on the global swine industry and have 
serious implications for animal welfare, consumer trust, efficient livestock production, and for 
providing an efficient source of protein worldwide. Vaccines and medications are routinely 
prescribed to maintain herd health against various infectious swine pathogens, but studies 
indicate that for some diseases, such as PRRS, these preventative methods have minimal success. 
Additionally, there is growing consumer interest in animals that are raised without antibiotics, 
suggesting that genetic improvement for increased disease resilience that minimizes the use of 
medicated feeds and antibiotics can be a worthwhile strategy to implement in the swine industry. 
Since complete resistance to disease is rare, disease resilience is an economically valuable trait 
because it is defined as the ability for an animal to maintain performance during infection 
(Albers et al., 1987; Doeschl-Wilson et al., 2012; Mulder and Rashidi, 2017). Chapters 3 and 4 
of this thesis investigated the potential of WUR and MSA as genetic indicators to select for 
increased disease resilience. The focus of this chapter is to discuss how these results can be used 
by swine breeders.  
One global swine disease that has been heavily studied is PRRS. Prior to the NDCM, the 
PHGC was established to investigate the genetic basis of host response to PRRS in pigs. Based 
on the work of this consortium, several additional tools to combat PRRS coalesced as a result of 
collaborative efforts among various other institutions and the swine breeding industry. A genome 
wide association study determined that a region of Sus scrofa chromosome 4 (SSC4) had a large 
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effect on host response to PRRS and explained 15.7% of the genetic variance for PRRS viral 
load and 11.2% for weight gain after experimental infection of nursery pigs with the PRRS virus 
(Boddicker et al., 2012). Through functional genomics, it was later discovered that the likely 
cause of these effects was a splice site mutation in the GBP5 gene (Koltes et al., 2015). They 
also determined that genotype at the WUR10000125 SNP, which was on commercially available 
SNP panels, while the splice site mutation was not, was in complete linkage disequilibrium with 
genotype at the GBP5 SNP that caused the splice site mutation. However, a major limitation of 
the latter result was that the animal subjects were from one genetic line. In order to investigate 
the WUR SNP further, the relationship between the genotype at WUR with the genotype at its 
putative causative mutation in the GBP5 gene were reexamined in Chapter 3 using a larger 
sample size and pigs from a variety of breeds and family lines. Since the GBP5 splice site 
mutation is the putative causative mutation for the effect of this region on host response to PRRS 
(Koltes et al., 2015), another question addressed in Chapter 3 is whether the GBP5 marker has a 
larger association with host response to PRRS than the WUR marker. While these two objectives 
directed their attention to the PRRS virus, in practice, there are many more infectious pathogens 
than just the PRRS virus. Thus, the final research question answered in Chapter 3 was whether 
genotype at the WUR SNP is also associated with disease resilience to a natural polymicrobial 
disease challenge in the NDCM.  
The great diversity of swine pathogens commonly found in swine barns creates a need for an 
efficient strategy to select for increased disease resilience. The main objective of Chapter 4 was 
to determine whether an in-vitro MSA on blood collected from young healthy pigs can be used 
as a genetic indicator for disease resilience to a polymicrobial disease challenge. In order for a 
genetic indicator to be effective, it must be heritable and have a considerable genetic correlation 
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with the trait of interest, in this case, disease resilience. The results presented in Chapter 4 
estimated the genetic parameters of the MSA to determine if mitogen stimulation can be used as 
a suitable genetic indicator to select for increasing disease resilience.  
 The focus of this discussion is to expand on the results in these studies by discussing the 
implementation of WUR and MSA as genetic indicators for disease resilience, and the 
limitations of these two studies.   
Implementation of WUR 
In Chapter 3, it was found that the WUR and GBP5 SNPs are in close, but not perfect 
linkage disequilibrium (LD). We found that that the LD between these two SNPs the population 
of pigs we investigated was 0.94 contrary to the perfect LD that was estimated by Koltes et al. 
(2015). Differences between genotype at WUR and GBP5 SNP were determined to have resulted 
from genetic recombination and not from genotyping errors.  
Using data from the PHGC trials, we found that, numerically, differences between 
genotypes were larger for the GBP5 SNP than for the WUR SNP for weight gain and viral load 
following experimental infection with the PRRS virus. This was as expected since the GBP5 
SNP is the putative causative mutation for this major gene for host response to PRRS. In Chapter 
3, we fitted both SNPs simultaneously to determine whether from adding the GBP5 SNP to a 
model that already included the WUR SNP explained a significant amount of extra variation. 
From this analysis it was determined that there was no statistical evidence to suggest that the 
GBP5 SNP was more strongly associated with host response to PRRS than the WUR SNP. On 
the SNP panels that were initially commercially available, the WUR SNP was included but the 
GBP5 SNP was not, and so the GBP5 SNP had to be genotyped separately in the PHGC trials. 
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This inconvenience thus raised the question if the WUR SNP is a suitable marker for the major 
QTL for host response to PRRS on SSC4. The GBP5 SNP has been included on more recent 
commercial SNP panels. However, since we determined that there was no statistical evidence 
suggesting that the effect of the GBP5 SNP is stronger than that of the WUR SNP, breeders can 
continue to use the WUR SNP and benefit from using either SNP to select for increased host 
response to PRRS.  
A favorable response in disease resilience from selection for the favorable genotypes at 
the WUR SNP is expected, since it was found that, with the exception of two traits, all disease 
resilience, growth, carcass, and feed intake traits in the NDCM were favorably associated with 
the favorable genotype at the WUR SNP. However, the effect of WUR genotype was statistically 
significant (p<0.05) for only three traits: (1) average daily gain in the challenge nursery, (2) 
number of treatments in the challenge nursery, and (3) number of treatments across the challenge 
and finisher pens. These statistically significant differences suggest that by selecting based on the 
favorable allele of WUR, the offspring of selected individuals are expected to have a higher 
growth rate and lower treatments in the challenge nursery. 
One strategy for implementing selection on genotype at the WUR SNP is by 
incorporating the WUR genotype into the selection index. Many breeding companies utilize an 
index that is composed of several traits that are given different weights to determine which 
animals would be the best selection candidates based on collected phenotypes. The WUR 
genotype can be included as another trait in the selection index since it was found that the 
favorable allele of WUR has favorable associations with many different traits. If financial 
constraints prevent phenotyping of animals in the candidate pool, then the genotype at the WUR 
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SNP can be used on its own as a tool to pre-select animals for further phenotyping, while 
increasing disease resilience.  
The populations used in this study (PHGC and NDCM) were in Hardy Weinberg 
Equilibrium for the WUR SNP. This is surprising for two reasons: (1) this population did not 
undergo random mating, and (2) purebred lines were crossed, which intrinsically creates more 
heterozygotes in the population if the parental alleles differ in allele frequency. The frequency of 
the G allele in commercial lines is small (Boddicker et al., 2014b), which is likely because the 
selection is done at the high health nucleus level, where there tends to be little presence of the 
PRRS virus and, therefore, there has not been direct or indirect selection pressure on the G allele. 
The low frequency also suggests that it is possible to substantially increase the prevalence of pigs 
with the G allele. Thus, breeders can continue to use the genotype at the WUR marker as the 
criterion for selecting parents and implement marker-assisted selection for increased disease 
resilience in their breeding programs.  
Implementation of MSA 
The MSA phenotypes investigated in Chapter 4 provide other opportunities for 
phenotypes that can be measured on young healthy pigs in the nucleus. Selection on an indicator 
trait that is heritable and genetically correlated to the trait of interest is expected to result in a 
correlated response to selection in the target trait. Correlated response depends on the heritability 
of the indicator trait and the genetic correlation between the indicator and target trait. Based on 
the results in Chapter 4, MSA to Con A provides the most promising genetic indicator traits to 
select for disease resilience. Response to Con A had among the highest estimates of heritability 
at each of the three time points and for AUC, ranging from 0.23 to 0.27 when using BIS and 
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from 0.17 to 0.30 when using the stimulated mean. Responses to PHA and PMA had estimates of 
heritability in similar ranges but heritability estimates for PWM and LPS were consistently low. 
Thus, consideration was narrowed down to Con A, PHA, and PMA. When broadly analyzing the 
observed trends of the estimates of genetic correlations of these mitogens with disease resilience 
traits, Con A had the most consistent estimates relative to expected trends, which were that MSA 
phenotypes were positively correlated with growth rate under disease and negatively with 
numbers of treatments and mortality. While estimates of genetic correlations were largest for 
PMA for some disease resilience traits, these estimates also had rather large standard errors, 
whereas estimates for Con A had relatively smaller standard errors and, thus, were considered to 
be more reliable. Overall, all three time points following stimulation with Con A were 
promising, and more research is needed in order to determine which time point is best. Based on 
the moderate estimates of heritability at each of the three time points for Con A and expected 
trends in correlations with disease resilience traits, a correlated response to selection can be 
expected from selection on Con A MSA phenotypes to indirectly increase overall disease 
resilience of the swine herd.    
Study Limitations 
 One limitation of the data from PHGC trials used in Chapter 3 is that the pigs were 
infected with only the North American strain of PRRS (NVSL). PRRS is recognized to be a 
multifaceted disease with high genetic variation, implying that multiple strains of PRRS exist 
and can evolve or appear in a short period of time. It is possible that the results obtained from the 
PHGC trials do not apply to all PRRS virus strains or could soon be outdated due to the fast 
evolution of the PRRS virus. It was found from the PHGC trials that there was a statistically 
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significant association between the WUR SNP genotype and PRRS viral load when using a 
North American strain of PRRS, NVSL-97-7895 (NVSL) (Boddicker et al., 2012). In a related 
study Hess et al. (2016) utilized a different North American strain, KS-2006-72109 (KS06) to 
investigate whether the WUR SNP was also associated with host response to PRRS in a 
genetically distinct North American strain of PRRS. This study determined that selection for host 
response to either of the genetically distinct strains is expected to increase host response to the 
other strain, implying that the effects of the two strains on host response to PRRS are similar.  
One limitation of the natural disease challenge trials used in Chapter 4 is that all animals 
were offspring of a Landrace x Yorkshire cross, although from seven different genetic sources. 
Similar to how certain breeds of pigs have better meat quality or maternal ability, there is 
evidence suggesting that some breeds have higher resilience to disease than others. For example, 
Petry et al. (2005) found that Meishan and Large White pigs are more resistant to the effects of 
the PRRS virus than pigs of the Duroc and Pietrain breeds. In addition, the US swine industry 
does not exclusively use Landrace x Yorkshire crosses, as there are several other commonly used 
breeds used, such as the Duroc, Berkshire, or Hampshire breeds. While the effect of genotype at 
the WUR SNP was observed in many breeds commonly used in the swine industry (such as the 
Duroc, Pietran, and the Large White), this is not the case for studies performed using MSA. This 
suggests that further research should be done to determine if the genetic parameters of the MSA 
in other commonly used breeds are consistent with those presented in Chapter 4 in order to 
accurately predict the response to selection in different breeds. 
Another limitation is that the results presented in Chapter 4 are based on in-vitro assays. 
There are several advantages to using an in-vitro assay to develop genetic indicator traits. One 
asset is that the mitogen does not need to applied to the pig directly, which would inherently 
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limit the use of each pig to just one mitogen. Additionally, this could lead to potential welfare 
problems, as the injection of a mitogen can cause significant pain or suffering to the animal. The 
collection of blood samples for in-vitro assays is much preferred for large scale projects such as 
those presented in Chapter 4, which consisted of thousands of pigs. One disadvantage of an in-
vitro assay, however, is that it relies on the assumption that the wide range of different immune 
responses a pig may face can be captured by a single triggering mitogen. While a mitogen is 
effective in activating certain pathways of the immune response, it does so in a systematic 
fashion, akin to the body’s response to a foreign antigen. It can be argued that this alone does not 
capture the diverse assortment of the body’s response to a foreign pathogen. If this assumption is 
false, then the MSA provides valuable information about the animal’s ability to activate a 
specific immune pathway, but not a specific immune response to any pathogen. Thus, any 
pathogen that would cause a response that involves a particular pathway would be correlated 
with the mitogen that stimulates the same pathway. More research should be done to investigate 
the genetic correlations of a mitogen with specific infectious pathogens that can provide more 
insight into the relationship between mitogen induced immune cell proliferation and disease.  
The last limitation to be discussed is the limitation of the natural disease challenge used 
in both Chapter 3 and 4. Contrary to the PHGC trials, where each pig was injected with a given 
amount of PRRSV, the NDCM was a natural challenge, designed to emulate conditions of a 
high-pressure disease environment, such as those seen in a commercial swine barn. The 
NDCM’s polymicrobial disease challenge consisted of over 30 different viruses, pathogens, and 
other infectious organisms. Pigs that were sick during the disease challenge were treated by 
veterinarians according to their observable symptoms. However, it was not determined which 
particular pathogen was the causative agent for any given illness. This leaves a gap in 
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information, as we were unable to narrow down our observations to any specific pathogen. For 
instance, many pigs required treatment due to respiratory illness. While PRRS is known to cause 
several respiratory symptoms, so can other diseases such as Swine Influenza and a myriad of 
other bacterial pathogens. Further research should be done to determine if there are genetic 
indicators that can be used specifically for just one disease. This may be useful for farms that fit 
a certain pathogenic profile, as not all farms will have the same pathogenic profile as the one 
used in the NDCM. While the pathogens used in the challenge are commonly found in North 
America, it would be useful to know if using a different combination of pathogens in a disease 
challenge will elicit different results than those presented in Chapters 3 and 4.  
Concluding Remarks 
The results presented in this thesis suggest that there not only is a substantial genetic 
component to a pig’s response to PRRS and a polymicrobial disease challenge, but also that 
selection for increased disease resilience in high-health nucleus breeding populations is possible. 
Swine producers can benefit from marker-assisted selection by genotyping pigs at either the 
GBP5 or WUR SNP, as the favorable allele for both of these markers is in low frequency. Swine 
producers can also benefit from using Concanavalin A in a mitogen stimulation assay conducted 
on blood samples from young healthy pigs to indirectly select for increased disease resilience, as 
response to this mitogen not only was moderately heritable (h2 = 0.24), but also had reasonable 
genetic correlations with all of the disease resilience traits collected in the polymicrobial natural 
challenge. Implementation of the WUR SNP or MSA for selection will not create pigs that are 
completely resistant to disease, but will reduce the financial costs of disease and allow breeders 
119 
 
an alternative to selection based on subjecting the nucleus herd to a disease challenge or 
collecting disease data at the commercial level.  
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